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For GWAS I, raw fluorescence data were generated, and subsequently transformed to binary 
files with averaged red and green fluorescence values per SNP bead. The amplitudes for the 
red signal were matched to the green signal by estimating a multiplication factor per subarray 
and per SNP such that heterozygote genotypes were mapped to zero and the homozygote 
genotypes to –1 and +1. The transformation Z=(green-correction array x correction SNP x 
red)/(green+corrected red) was used as the mapping function. The mean heterozygote Z-
transformed red/green value for each SNP and each subarray was shifted to zero by iterative 
adjustment of the correction factors. Ten iterations were used, which was sufficient for 
convergence. This procedure resulted in high quality, one-dimensional genotype clusters, 
allowing genotyping based on arrays rather than individual SNPs. The Z values were 
converted to genotypes. For amplitude analysis the green+corrected red score was used for 
each SNP, and the average for all SNPs was subtracted, resulting in a residue amplitude 
score. This procedure removed more than 90% of the variance of amplitude differences 
between SNPs. We compared the results of this procedure with the Illumina standardization 
and found only very marginal differences. Therefore, in GWAS II the genotypes were scored 
with Illumina standardized software Beadstudio.  
Quality control measures included Hardy-Weinberg equilibrium of p>10-7, missing genotype 
rate per individual <0.01, missing genotype rate per SNP <0.01 and a minor allele frequency 
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cut off of 0.01. Markers with Mendelian errors in phase I were excluded from analysis. We 
excluded related subjects (IBD >12.5 %) and non-Caucasian subjects, as assessed by 
principal components analysis performed with EIGENSTRAT (1). All statistical analysis were 
performed using PLINK v1.07 (2). 
 
Multicenter Asthma Genetics in Childhood Study (MAGICS) 
Asthma cases from the Multicentre Asthma Genetics in Childhood Study were diagnosed by 
a pediatric pulmonologist or allergologist on the basis of clinical examination, case history 
and objective tests of lung function (3). Asthmatics (mean age 10.95 yr) were recruited from 7 
centers located in Germany and Austria (Wesel, Bochum Cologne, Freiberg, Munich, 
Feldkirch and Vienna), and as a reference, 800 German children (mean age 9.62 yr) from 
Dresden (n = 400) and Munich (n = 400) were randomly drawn from all German children with 
DNA available in the cross sectional ISAAC Phase II study (4). DNA of all these children was 
genotyped with the Illumina Sentrix HumanHap300 BeadChip. After quality control and 
elimination of markers with low minor-allele frequencies (<0.5%), extreme Hardy–Weinberg 
equilibrium statistics (χ2 >25) or low genotyping call rates (<95%), we retained 307,328 SNPs 
for analysis. SNPs selected for replication were tested using PLINK version v1.07 (2). All 
study methods were approved by the appropriate ethics committees and written parental 
consent was obtained for all participants.  
 
The Avon Longitudinal Study of Parents and Children (ALSPAC)  
ALSPAC is a longitudinal, population-based birth cohort study whose protocol has been 
described previously (5). Ethical approval was obtained from the ALSPAC Ethics and Law 
Committee and Local Research Ethics Committees, and written informed consent was 
obtained for all measurements. 
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ALSPAC recruited 14,541 pregnant women resident in Avon, UK with expected dates of 
delivery 1st April 1991 to 31st December 1992(5) 14,541 is the initial number of pregnancies 
for which the mother enrolled in the ALSPAC study and had either returned at least one 
questionnaire or attended a “Children in Focus” clinic by 19/07/99. Of these initial 
pregnancies, there were a total of 14,676 fetuses, resulting in 14,062 live births and 13,988 
children who were alive at 1 year of age. 
A total of 9912 children were genotyped using the Illumina HumanHap550 quad genome-
wide SNP genotyping platform by 23andMe subcontracting the Wellcome Trust Sanger 
Institute, Cambridge, UK and the Laboratory Corporation of America, Burlington, NC, USA. 
Children were excluded from further analysis on the basis of having incorrect gender 
assignments; minimal or excessive heterozygosity (<0.320 and >0.345 for the Sanger data 
and <0.310 and >0.330 for the LabCorp data); disproportionate levels of individual 
missingness (>3%); evidence of cryptic relatedness (measured as proportion of identity by 
descent (IBD >0.1) and insufficient sample replication (IBD <0.8). The remaining children 
were assessed for evidence of population stratification by multidimensional scaling analysis 
and compared with Hapmap II (release 22) European descent (CEU), Han Chinese, 
Japanese and Yoruba reference populations; all children with non-European ancestry were 
removed to avoid population stratification, however this step removed very few children given 
the nature of the study and as a result had very little impact in the overall findings of the 
study. SNPs with a minor allele frequency of <1%, a call rate of <95% or evidence for 
violations of Hardy-Weinberg equilibrium (p<5E-7) were removed. Autosomal genotypic data 
were subsequently imputed using Markov Chain Haplotyping software (MACH v.1.0.16, Li et 
al. 2010) and phased haplotype data from CEU children (Hapmap release 22, Phase II NCBI 
B36, dbSNP 126) based on a cleaned dataset of 8,365 children and 464,311 autosomal 
SNPs. After imputation, all SNPs with indication of poor imputation quality (r2<0.30) were 
removed. Genotyping and cleaning has been previously documented (6).  
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Asthma at 7½ years was defined as a positive response to the question, “Has a doctor ever 
told you that your child has asthma?” in a questionnaire sent to their mothers at 91 months 
after birth.  
Of 8,365 children with clean GWAS data, 5,562 had asthma status at age 7½ years available 
and 1,096 (19.7%) had asthma. Replication studies of selected SNPS were performed in 
PLINK regressing expected allelic dosage on case-control status.  
 
The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens 
(TENOR) multicenter study 
Subjects with severe or difficult to treat asthma were recruited as part of the TENOR study 
(7). These 438 cases represent adult subjects with asthma (mean age 47 years, 63% 
female), with mean FEV1 of 78.4 % of predicted, and a high percentage of atopy (394/409 
patients had one or more positive skin tests) (8). DNA was isolated by using standard 
protocols, and SNP genotyping was performed with the Illumina HumanCNV370 BeadChip 




The SARP non-Hispanic white population was composed of subjects from the NHLBI-funded 
SARP, and the CSGA population was from the NHLBI CSGA studies. Subjects with mild-to-
severe asthma were recruited at SARP centers and carefully characterized, including 
baseline spirometric results and total serum IgE levels (9), (10). Subjects with asthma who 
were studied in CSGA by the Wake Forest investigators using a similar protocol were 
included in the analyses (11). In addition, healthy subjects without asthma recruited by SARP 
and CSGA investigators were included in the analysis. Controls were recruited from the 
same medical centers, and had no personal or first-degree relative family history of asthma. 
SARP and CSGA studies were approved by the appropriate Institutional Review Board at the 
participating sites including appropriate informed consent. 
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This sample consisted of 661 cases with asthma (mean age 33.1 years) and 363 age 
matched controls. The majority (65%) was female. Mean FEV1 was 79.6 % of predicted, and 
487 of 590 tested had a positive skin prick test for one or more aeroallergens (8). 
Genotyping and QC: Genotyping was performed on the Illumina 1Mv1 platform, with 
individual genotypes called using clustering algorithms as implemented in the BeadStudio 
software by Illumina. For TENOR, CSGA and SARP: Samples were removed if they (1) had 
low genotyping call rates (<95%), (2) were discrepant or ambiguous for genetic sex 
(heterozygous haploid genotype percentage >0.01 or X-chromosome homozygosity F >0.9), 
(3) were not non-Hispanic whites as described), (4) failed the check for family relatedness 
(PI_HAT >0.125), or (5) were detected as an outlier (>6 SDs for the first or second principal 
component). After subjects meeting these criteria were excluded, SNPs were removed if (1) 
the call rates were still low (95%), (2) inconsistent with Hardy-Weinberg equilibrium (p<10-4) 




Lung eQTL analysis 
Non-tumor lung tissues were collected from patients who underwent lung resection surgery 
at three participating sites: Laval University (Quebec City, Canada), University of Groningen 
(Groningen, The Netherlands), and University of British Columbia (Vancouver, Canada) (12). 
At Laval, lung specimens were collected from patients undergoing lung cancer surgery and 
stored at the “Institut universitaire de cardiologie et de pneumologie de Québec” (IUCPQ) 
site of the Respiratory Health Network Tissue Bank of the “Fonds de recherche du Québec – 
Santé” (www.tissuebank.ca). Written informed consent was obtained from all subjects and 
the study was approved by the IUCPQ ethics committee. At Groningen, lung specimens were 
provided by the local tissue bank of the Department of Pathology and the study protocol was 
consistent with the Research Code of the University Medical Center Groningen and Dutch 
national ethical and professional guidelines (“Code of conduct; Dutch federation of 
biomedical scientific societies”; http://www.federa.org). At Vancouver, the lung specimens 
were provided by the James Hogg Research Center Biobank at St Paul's Hospital and 
subjects provided written informed consent. The study was approved by the ethics 
committees at the UBC-Providence Health Care Research Institute Ethics Board. 
Genome-wide gene expression and genotyping profiles were obtained using a custom 
Affymetrix array, Gene Expression Omnibus (GEO) platform GPL10379, and the Illumina 
Human1M-Duo BeadChip array, respectively. Gene expression data are available through 
the GEO repository with the accession number GSE23546. Standard quality controls were 
performed as described previously (12). Only 1095 subjects from Laval, Groningen, and UBC 
subjects that passed genotyping and expression quality controls were included in this study. 
Probes located two Mb to the left and right of the base pair position of the top SNP were 
selected for the cis-eQTL analysis for that SNP (genome build reference 36.3). EQTL 
analyses were performed per site and then meta-analyzed. To correct for technical variance, 
principal components were calculated on the residuals of a linear regression on the gene-
expression data with correction for gender, disease, age and smoking. Principal components 
which explained more than 5% of the variance were added as covariates in the eQTL 
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analysis on the gene-expression data. eQTL analysis was performed using a linear 
regression with correction for gender, disease, age, smoking and technical variance 
(principal components). 
Selected probes were checked for any known polymorphisms in the probe (primer 
polymorphisms) (13). If primer polymorphisms were found with a minor allele frequency 
≥0.05, the gene transcript are shown in table E7b, but not used in the conclusions. A p-value 





Association of additional phenotypes within asthma patients in the DAG cohort 
Airway wall biopsies 
In 98 of the asthmatics (11%) in this GWAS, airway wall biopsies were taken (14). In these 
biopsies the following markers were determined: CD4+ cells, neutrophils and eosinophils. 
Values were log transformed to reach normal distribution. 
 
Spirometry measurements and severity of BHR 
In 909 asthmatics (98%), Force Expiratory Volume in one second (FEV1) was measured with 
a calibrated water-sealed spirometer according to the standardized guidelines(15). 
650 Subjects (71%), performed a BHR test using tidal breathing of a directly acting stimulus 
(histamine or methacholine) (15). Patients were bronchial hyperresponsive when a 20% fall 
of FEV1 compared to baseline was reached, when nebulizing with a concentration ≤9.8 
mg/ml methacholine bromide (equaling ≤8 mg/ml methacholine chloride) or ≤8 mg/ml 
histamine. Only asthmatics with data on smoking and steroid use were included for these 
analyses. 
Severity of BHR was measured with a slope. The slope was calculated by dividing the 
difference between FEV1 at baseline and at the dose step at which a 20% fall or more in 
FEV1 was reached, by the dose was taken at this last step. We divided the BHR slopes of the 
30-second tidal breathing method by 4 in order to compare the slope of the 30-second tidal 




IgE and eosinophils were determined in blood. Total IgE was determined in 781 asthmatics 
(85%) (Mini Vidas, Biomerieux, France) and eosinophils in 777 asthmatics (84%). 
 
Age of onset 
9 
 
In 729 asthmatics (79%), age of onset of the disease was assessed with a self-reported 
questionnaire or by examining the medical history of asthmatics.  
 
Corticosteroid use 
Data on corticosteroid use in the last 12 months before the airway responsiveness challenge 
test was available for 905 asthmatics (98%). 
 
Atopy 
Atopy was measured in 673 asthmatics (74%) and defined as one or more positive tests 




Supplementary table E1: Genome wide association studies in asthma: phenotype definition and Odds Ratios 
 
First author (ref) Asthma definition Chr.  Gene rs number Risk 
allele 
OR, 95%CI Comments 
Torgerson (16) Doctor’s 
diagnosis  




1 PYHIN1 rs1102000 T 1.32(1.17-1.46) Afr Am /Carib pop. 
 2 IL1RL1 rs10173081 C 1.20(1.11-1.29) All US ethnicities 
 5 TSLP rs1837235 C  1.19(1.12-1.27) All US ethnicities 
 9 IL33 rs2381416 C 1.18(1.08-1.28)  All US ethnicities 
 17 GSDMB rs11078927 C  1.27(1.20-1.34)  All US ethnicities 
Fereira (17) Doctor’s 
diagnosis 
1 IL6R rs41296267 T 1.09 (1.06-1.12) Australian discovery 
 11 11q13.5 rs7130588 G 1.09 (1.06-1.13) LRRC32 is closest gene  
Himes (18) Childhood onset 
asthma, all 
patients had BHR 
5 PDE4D rs1588265 A G: Protective Allele 
0.85 (0.77-0.93) 
A: Risk allele 1.18 
(1.08-1.30) 
OR in discovery and 
replication populations; 
OR in discovery: 0.60 
(0.48-0.71) 




17 ORMDL3 rs7216398 T NA OR = 1.45 in replication 
sample 
  17 GSDMA rs3894194 A 1.17 (1.11-1.23) GABRIEL meta-analysis 
 17 GSDMB rs2305480 G 1.18 (1.11-1.23) GABRIEL 
 6 HLA-DQ rs9273349 C 1.18 (1.13-1.24) GABRIEL 
 22 IL2RB rs2284033 G 1.12 (1.08-1.16) GABRIEL 
 2 IL18R1/IL1RL1 rs3771166 G 1.15 (1.10-1.20) GABRIEL 
 9 IL33 rs1342326 C 1.20 (1.13-1.28) GABRIEL 
 15 SMAD3 rs744910 G 1.12 (1.09-1.16) GABRIEL 




1 DENND1B rs2786098 C 1.42 (1.28-1.59) European Ancestry 
population (CHOP) 
Noguchi (21) Doctor’s 
diagnosis in 
children 
6 HLA-DP rs987870 G 1.40 (1.26–1.55) Japanese population 
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Hirota (22) Doctor’s 
diagnosis in 
adults 
4  rs7686660 T 1.16 (1.11-1.21) Japanese population 
  6 HLA-DQ rs404860 A 1.21 (1.16-1.25) Japanese population 
  10 Gene desert, 
GATA3 1mB 
rs10508372 C 1.16 (1.12-1.21) Japanese population 
  12 a.o.IKZF4 rs1701704 G 1.19 (1.14-1.25) Japanese population 
Schauberger (23) Doctor’s 
diagnosis in 
children 
1 ATPAF1 rs2289447 C NA Caucasian European 






atopy status by 
skin prick test 
17 PERLD1 rs2941504 G 0.78 (0.653-0.941) Chinese population 
Lasky-Su (25) Doctor’s 
diagnosis 
6 HLA-DQA1 rs9272346 G NA Adult Caucasian 
population 
Bonnelyke (26) with repeated 
acute 
hospitalization 
7 CDHR3 rs6967330 A 1.26 (1.18-1.33) Caucasian population of 
children 
        
 
Only studies with genome wide significant results after replication ( p <5*10-8) were selected. Odds Ratios of initial study are reported.  
CHR: Chromosome; OR: Odds Ratio; CI: Confidence interval; BHR: Bronchial Hyperresponsiveness; NA: Not annotated 
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  ALL GWAS GWAS I  GWAS II 
  Cases (n=920) 
Controls 
(n=631) Cases (n=468) 
Controls 
(n=120) Cases (n=452) 
Controls 
(n=511) 
Characteristics         
  Height (m) 1.68 ± 0.17 1.78 ± 0.07 1.69 ± 0.15 1.70 ± 0.08 1.68 ± 0.79 1.79 ± 0.06 
  Weight (kg) 71 ± 22 76 ± 12 71 ± 21 76 ± 12 71 ± 24  
  Gender (male) 430 (47) 557 (84) 215 (46) 46 (38) 215 (48) 511 (100) 
  Age (years) 34 ± 16 57 ± 6 33 ± 15.3 50 ± 8.2 36 ± 16 58 ± 5 
Smoking, n (%)         
  Current smoker 147 (16) 556 (88) 69 (15) 45 (37) 78 (18) 511 (100) 
  Never smoker 544 (59) 32 (5) 280 (60) 32 (27) 264 (58) - 
  Ex-smoker 226 (25) 43 (7) 118 (25) 43 (36) 108 (24) - 
  Pack years 7 [2;16] 34 [25;44] 5 [2;13] 14 [6;25] 8 [2;19] 34 [28;44] 
Steroids use in last 12 months, n 
(%)         
  Oral steroids 51 (6) 1 (1) 16 (4) - 35 (8) - 
  Inhaled steroids 506 (55) - 298 (64) - 208 (58) - 
  Oral and inhaled steroids 23 (2) - 13 (3) - 10 (2) - 
  No steroids 325 (35) 631 (100) 130 (29) 119 (100) 195 (43) 511 (100) 
Lung function         
  FEV1 % predicted 86 ± 21 103 ± 12 85 ± 21 101 ± 13 88 ± 21 104 ± 11 
Hyperresponsiveness         
  PC20 methacholine (mg/ml) 0.67 [0.18;2.37] - 1.89 [0.59;4.82] - 0.41 [0.12;1.12] - 
  PC20 histamine (mg/ml) 3.48 [1.14;11.23] - 2.98 [0.90;9.45] - 
5.89 
[1.70;12.76] - 
Blood         
  Eosinophils, 10-7/l 17 [10;29] 7 [3;12] 15 [8;26] 7 [3;12] 18 [10;32] - 
  Total IgE, kU/l 130 [44;375] 20 [9;52] 143 [45;469] 20 [9;52] 115 [42;309] - 
Atopy (yes) (n=673) 575 (74%) - 380 (83%) - 195 (90%) - 
Studies included in the DAG 
cohort (number of asthmatics %) 920 (100) 980 (100) 468 (100) 469 (100) 452 (100) 511 (100) 
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  SITA (27) 35 (4) - - - 35 (8) - 
  AST (28) 22 (2) - - - 22 (5) - 
  Nocturnal asthma (29) 39 (4) - - - 36 (8) - 
  SGO (30) 10 (1) - 10 (2) - - - 
  Stepdown (31) 64 (7) - - - 64 (14) - 
  KGO (32) 50 (6) - 50 (11) - - - 
  PIAMA (33) 63 (7) - 22 (5) - 41 (9) - 
  Prevasc (34) 21 (2)   -   21 (4) - 
  ELON (35) 6 (1) - - - 6 (1) - 
  Beatrixoord families (36) 229 (25) 150 (16) 130 (28) 150 (33) 99 (22) - 
  Trios (36) 299 (32) 316 (32) 256 (54) 316 (67) 43 (10) - 
  Van Lookeren (37) 60 (6) - - - 60 (13) - 
  Smoking in asthma (14) 25 (3) - - - 25 (6) - 
  Copacetic (11) - 511 (52) - - - 511 (100) 
*Not all controls in GWAS I have a phenotype; this is due to the 349 pseudo controls. In these controls the untransmitted alleles from father and 
mother of asthmatics out of GWAS I were used as the genotype.  
Mean ±Standard deviation; Median [range]; Number (%)
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Supplementary figure E3: Manhattan plot of Dutch Asthma GWAS on asthma with presence 
of bronchial hyperresponsiveness 
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Supplementary figure E4: QQ-plots of GWAS I, GWAS II and the meta-analysis of the Dutch 






Supplementary figure E5: Linkage disequilibrium plot of asthma-associated SNPs at the 



































Association in literature 
rs1449302 & rs13091963 ABI3BP Involved in stress induced premature senescence (SIPS), which could lead to cellular senescence and tumor 
suppression in lung cancer via oxidative stress. The precise mechanisms are unclear (38, 39) 
rs4132177 NAF1 Knock-out mouse shows early senescence accompanied by a shortened lifespan via degenerations of the 
mitochondria thereby inducing autophagy which leads to cell death. A second mechanism is by endoplasmatic 
reticulum IP3 Ca2+ leak channels in skeletal muscle (40, 41) 
rs2596560 MICA MICA is associated with the RSV infection in young childhood which could lead to asthma (42) 
rs2290400 & rs2305480 GSDMB Association with early childhood asthma onset, precise mechanisms unclear (43) 
# SNPs of genes in bold, italic and underlined are genic, other SNPs are intergenic 
SNP; Single Nucleotide Polymorphism 
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Supplementary table E8: Overview of gene transcripts identified in the eQTL analysis  
Locus of the identified gene, SNP which leads to an eQTL in the gene, risk allele of the SNP leading to the eQTL, up or down regulation of the 
gene transcript by risk allele of the SNP and function of the gene (known in genecards.org) 
 
Gene locus SNP Risk 
allele 
regulation function* 
ABI3BP 3q12.2 rs13091963 
rs1449302 
A      
C 
up Involved in stress induced premature senescence (SIPS), which could lead to cellular 
senescence and tumor suppression in lung cancer via oxidative stress. Precise 
mechanisms are unclear 
HCG18 6q21.3 rs2596560 C down Function unknown 
FLOT1 6q21.3 rs2596560 C up May act as a scaffolding protein within caveolar membranes, functionally participating 
in formation of caveolae or caveolae-like vesicles 
HLA-A 6q21.3 rs2596560 C up&down Involved in the presentation of foreign antigens to the immune system 
PSORS1C1 6q21.3 rs2596560 C down This gene is one of several genes thought to confer susceptibility to psoriasis and 
systemic sclerosis. 
HLA-C 6q21.3 rs2596560 C down Involved in the presentation of foreign antigens to the immune system 
ATP6V1G2 6q21.3 rs2596560 C down Catalytic subunit of the peripheral V1 complex of vacuolar ATPase (V-ATPase). V-
ATPase is responsible for acidifying a variety of intracellular compartments in 
eukaryotic cells 
NOTCH4 6q21.3 rs2596560  C      down Suggested to play a role in angiogenesis and airway remodeling  
TUBB 6q21.3 rs2596560  C         up Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an 
exchangeable site on the beta chain and one at a non-exchangeable site on the alpha 
chain 
BAT2 6q21.3 rs2596560 C         down May play a role in the regulation of pre-mRNA splicing 
HLA-DQB1 6q21.3 rs2596560  C         down Binds peptides derived from antigens that access the endocytic route of antigen 
presenting cells (APC) and presents them on the cell surface for recognition by the 
CD4 T-cells. 
ZFP57 6q21.3 rs2596560 C         up Transcription regulator required to maintain maternal and paternal gene imprinting, a 
process by which gene expression is restricted in a parent of origin-specific manner 
by epigenetic modification of genomic DNA and chromatin, including DNA methylation 
SFTA2 6q21.33 rs2596560 C up SFTA2 (surfactant associated 2) is a protein-coding gene 
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RNF5 6q21.3 rs2596560 C up The protein encoded by this gene contains a RING finger, which is a motif known to 
be involved in protein-protein interactions. This protein is a membrane-bound ubiquitin 
ligase. It can regulate cell motility by targeting paxillin ubiquitination and altering the 
distribution and localization of paxillin in cytoplasm and cell focal adhesions 
HLA-DPB1 6q21.3 rs2596560 C up HLA-DPB belongs to the HLA class II beta chain paralogues. This class II molecule is 
a heterodimer consisting of an alpha (DPA) and a beta chain (DPB), both anchored in 
the membrane. It plays a central role in the immune system by presenting peptides 
derived from extracellular protein 
HLA-DRB1  6q21.3 rs2596560 C up HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a 
heterodimer consisting of an HLA-DRB1 belongs to the HLA class II beta chain 
paralogs. The class II molecule is a heterodimer consisting of an alpha (DRA) and a 
beta chain (DRB), both anchored in the membrane. It plays a central role in the 
immune system by presenting peptides derived from extracellular proteins by 
presenting peptides derived from extracellular proteins 
GSDMB 17q12.21 rs2305480 
rs2290400 
A      
C 
down May play a role as secretory or metabolic product involved in secretory pathway. May 
also play a role in achieving and maintaining the final differentiation state of epithelial 
cells 
GSDMA 17q12.21 rs2305480 
rs2290400 
A            
C 
up Induces apoptosis 
CRKRS 17q12.21 rs2305480 
rs2290400 
A            
C 
up Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA 
splicing 
PERLD1 17q12.21 rs2305480 
rs2290400 
A            
C 
down Involved in the lipid remodeling steps of GPI-anchor maturation.  
ORMDL3 17q12.21 rs2305480 
rs2290400 
A            
C 
down Negative regulator of sphingolipid synthesis. May indirectly regulate endoplasmic 
reticulum-mediated Ca(+2) signaling 
PNMT 17q12.21 rs2290400 C down Converts noradrenaline to adrenaline 
IKZF3 17q12.21 rs2290400 C up Transcription factor that plays an important role in the regulation of lymphocyte 
differentiation. Plays an essential role in regulation of B-cell differentiation, 
proliferation and maturation to an effector state. Involved in regulating BCL2 
expression and controlling apoptosis in T-cells in an IL2-dependent manner 
* function as known on genecards.org 





Supplementary table E9: Results of eQTL analysis.  
A. Gene transcripts without a primer polymorphism in one of the probes. 
SNP 
Risk 




stop eQTL beta p-value 
rs13091963 G ABI3BP 102127882 102190794 -0.11 1.95*10-15 
   ABI3BP 101950689 101951270 -0.06 2.52*10-07 
rs1449302 T ABI3BP 102127882 102190794 -0.06 2.38*10-08 
rs2596560 T ZFP57 29748256 29766468 0.53 2.66*10-19 
   HLA-A 30019070 30085606 0.10 1.32*10-11 
   HLA-C 31344828 31347827 -0.04 5.41*10-10 
   TUBB 30796135 30801172 0.05 5.88*10-10 
   HLA-DQB1 32735222 32742439 -0.06 5.43*10-08 
   ATP6V1G2 31620220 31622606 -0.12 7.52*10-08 
   HLA-DQB1 32735634 32742444 -0.06 1.11*10-07 
   HLA-DQB1 32735641 32742443 -0.06 1.44*10-07 
   NOTCH4 32270598 32299822 -0.07 2.73*10-07 
   HLA-DRB1 32594309 32665569 0.13 5.99*10-07 
   HLA-A 30018309 30021632 -0.10 1.19*10-06 
   BAT2 31696428 31713533 -0.04 1.26*10-06 
   SFTA2 31007105 31007931 0.06 1.85*10-06 
   PSORS1C1 31190601 31215816 -0.17 2.42*10-06 
   RNF5 32254139 32256548 0.04 2.75*10-06 
   HLA-DPB1 33151737 33162954 0.09 8.07*10-06 
rs2290400 T GSDMB 35314375 35328429 0.14 2.24*10-46 
   GSDMA 35372751 35387545 -0.33 3.95*10-25 
   CRKRS 34942504 34943280 -0.08 3.80*10-24 
   ORMDL3 35330821 35337380 0.07 4.61*10-19 
   CRKRS 34941825 34942053 -0.10 1.82*10-15 
   CRKRS 34871264 34944326 -0.10 2.64*10-14 
   PERLD1 35080901 35097836 0.04 1.30*10-08 
   IKZF3 35174726 35273967 -0.07 4.70*10-06 
    PNMT 35078032 35080254 0.11 7.65*10-06 
rs2305480 G GSDMB 35314375 35328429 0.14 3.41*10-42 
   GSDMA 35372751 35387545 -0.40 3.55*10-37 
   CRKRS 34942504 34943280 -0.07 9.38*10-17 
   ORMDL3 35330821 35337380 0.06 5.61*10-16 
   CRKRS 34941825 34942053 -0.09 1.22*10-12 
   CRKRS 34871264 34944326 -0.09 9.40*10-12 
    PERLD1 35080901 35097836 0.03 9.38*10-07 
 




B. Gene transcripts with a primer polymorphism in one of the probes of the gene transcripts, 








stop eQTL beta p-value 
rs2596560 T HLA-C 31344506 31347861 -0.16 1.12*10-27 
   MICB 31573944 31586877 0.10 6.83*10-14 
   APOM 31731649 31733965 -0.08 3.19*10-11 
   HLA-G 29903802 29905448 -0.10 1.24*10-10 
   HCP5 31538937 31541460 -0.09 4.85*10-09 
   C6orf12 30081147 30081403 0.13 6.23*10-09 
   NCR3 31664650 31668741 0.12 6.70*10-09 
   VARS2 30989960 31002212 -0.07 4.52*10-08 
   HLA-DQB2 32831853 32839245 0.32 1.02*10-07 
   LST1 31661949 31664664 0.06 6.32*10-07 
   HLA-G 29902734 29906878 -0.10 4.05*10-06 
    HCG4P6 30000478 30002971 0.12 1.03*10-05 
SNP; Single Nucleotide Polymorphism 
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Supplementary table E10: All results of the in depth phenotyping 
Association of top hit SNPs with age of onset of asthma, steroid use, atopy (positive skin 
prick test), FEV1% predicted, BHR severity, eosinophils, total IgE, CD4+, neutrophils and 
eosinophils (EPX) (analyzed in an additive regression model). 
 
* Not all subphenotype are measure in all asthmatics 
SNP: Single Nucleotide Polymorphism; CHR: Chromosome; MAF: Minor allele frequency; OR: Odds 
Ratio; Se: Standard error; P: p-value 
 CHR 3 3 4 6 17 17 
 SNP rs1449302 rs13091963 rs4132177 rs2596560 rs2305480 rs2290400 
 risk allele T G A C G T 
Phenotypes MAF 0.56 0.72 0.05 0.29 0.56 0.51 
Age onset OR 0.84 0.85 1.09 1.13 1.15 1.12 
≤4 years n=312 Se 0.11 0.12 0.22 0.12 0.12 0.11 
≥4 years n=417 P 0.11 0.18 0.7 0.31 0.24 0.32 
Age onset OR 0.86 1.06 0.86 1.1 1.12 1.08 
≤16 years n=553 Se 0.12 0.13 0.23 0.13 0.12 0.12 
≥16 years n=176 P 0.2 0.62 0.52 0.47 0.35 0.48 
Steroids OR 0.83 0.83 1.01 0.94 0.92 0.93 
yes n=580 Se 0.1 0.11 0.2 0.11 0.1 0.1 
no n=325 P 0.24 0.1 0.96 0.58 0.44 0.47 
Atopy OR 0.78 0.83 0.58 1.5 1.14 1.11 
n=575 Se 0.16 0.18 0.26 0.18 0.16 0.15 
no=98 P 0.11 0.3 0.03 0.03 0.4 0.49 
Eos Beta -0.001 0.02 0.02 -0.02 -0.04 -0.02 
n=777 Se 0.05 0.05 0.1 0.05 0.05 0.05 
  P 0.98 0.71 0.87 0.67 0.49 0.67 
FEV1 % predicted Beta -1.1 -0.96 -0.4 0.87 0.04 0.57 
n=909 Se 0.96 1.09 1.93 1.05 0.99 0.97 
  P 0.25 0.38 0.84 0.41 0.97 0.56 
Total IgE Beta -0.19 -0.22 -0.05 -0.002 0.12 0.12 
n=781 Se 0.08 0.09 0.16 0.09 0.08 0.08 
  P 0.02 9.50E-03 0.76 0.98 0.14 0.13 
BHR severity Beta 0.01 -0.03 -0.22 -0.01 0.15 0.09 
n=650 Se 0.09 0.1 0.17 0.09 0.09 0.08 
  P 0.95 0.74 0.18 0.92 0.08 0.26 
Neutrophils Beta -0.08 -0.09 0.4 -0.04 -0.02 -0.1 
n=98 Se 0.14 0.15 0.3 0.14 0.14 0.14 
  P 0.55 0.56 0.18 0.76 0.86 0.45 
CD4 Beta 0.2 0.18 -0.36 0.12 0.4 0.34 
n=98 Se 0.16 0.18 0.36 0.16 0.16 0.16 
  P 0.23 0.34 0.32 0.47 0.02 0.04 
EPX  Beta -0.17 -0.14 0.14 0.14 0.31 0.21 
n=98 Se 0.15 0.17 0.33 0.15 0.15 0.15 
  P 0.26 0.39 0.67 0.36 0.04 0.15 
24 
 
Supplementary table E11: Overview of STRING network analyses; all FDR significant GO 
biological processes (A) and KEGG (B) pathway analysis.  
 
A: 
Go biological pathway Number of 
genes 
P-value* Genes 
Regulation of interferon-gamma production 8 1.47E-8 HLA-DPB1, HLA-DRB1, HLA-
A, IL18R1, PDE4D, GATA3, 
IL1RL1, IL33 
Positive regulation of interleukin-5 production 4 9.11E-7 IL33, IL1RL1, GATA3, PDE4D 
Regulation of interleukin-5 production 4 4.01E-5 IL33, IL1RL1, GATA3, PDE4D 
Positive regulation of cytokine production 8 2.04E-4 HLA-DPB1, HLA-A, IL1RL1, 
GATA3, IL18R1, PDE4D, IL6R, 
SMAD3 
Cellular response to cytokine stimulus 9 2.96E-4 HLA-DPB1, HLA-DRB1, HLA-
C, HLA-A, IL2RB, IL18R1, 
GATA3, IL1RL1, HLA-DQB1 
Cytokine-mediated signaling pathway 8 2.96E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, GATA3, PDE4D 
Negative regulation of interferon-gamma 
production 
4 2.96E-4 HLA-C, HLA-DRB1, IL33, 
IL1RL1, HLA-DQB1 
Interferon-gamma-mediated signaling pathway 5 3.87E-4 HLA-DPB1, HLA-DRB1, HLA-
C, HLA-A, HLA-DQB1 
Regulation of leukocyte activation 8 3.95E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, IL-33, IL1RL1, 
IKZF3, MICA 
Positive regulation of leukocyte activation 7 4.11E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, IL-33, IL1RL1, 
GATA3 
Positive regulation of cell activation 7 4.73E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, IL-33, IL1RL1, 
GATA3 
Regulation of cell activation 8 5.05E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, IL-33, IL1RL1, 
IKZF3, MICA 
Response to cytokine 9 5.83E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-C, HLA-A, IL18R1, 
IL2RB, GATA3, IL1RL1 
T cell receptor signaling pathway 5 5.83E-4 HLA-DPB1,HLA-DRB1, HLA-
DQB1, GATA3, PDE4D 
Regulation of adaptive immune response based 
on somatic recombination of immune receptors 
built from immunoglobulin superfamily domains 
5 8.29E-4 HLA-DRB1, HLA-DQB1, HLA-
C, IL33, IL1RL1 
Cellular response to interferon-gamma 5 8.48E-4 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-C, HLA-A  
Negative regulation of immune response 5 8.48E-4 HLA-DRB1, HLA-A, IL33, 
IL1RL1, MICA 
Regulation of adaptive immune response 5 1.02E-3 HLA-DRB1, HLA-A, IL33, 
IL1RL1, HLA-DQB1 
Positive regulation of cell adhesion 7 1.23E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, GATA3, 
SMAD3. ABI3BP 




Negative regulation of defense response 5 1.24E-3 HLA-DRB1, HLA-A, GATA3, 
SMAD3, MICA 
Antigen receptor-mediated signaling pathway 5 1.24E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, GATA3, PDE4D 
Response to interferon-gamma 5 1.29E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-C, HLA-A 
Adaptive immune response based on somatic 
recombination of immune receptors built from 
immunoglobulin superfamily domains 
5 1.29E-3 HLA-DRB1, HLA-DQB1, 
GATA3, IL18R1, MICA 
Positive regulation of interferon-gamma 
production 
4 1.34E-3 HLA-DPB1, HLA-A, IL18R1, 
PDE4D 
Regulation of cell killing 4 1.61E-3 HLA-BRB1,HLA-DQB1, MICA 
Regulation of immune response 9 2.55E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, IL33, IL1RL1, GATA33, 
SMAD3, PDE4D, MICA 
Regulation of response to external stimulus 8 3.67E-3 HLA-DRB1, HLA-A, IL33, 
IL1RL1, GATA3, SMAD3, 
RNF5, IL6R 
Adaptive immune response 5 3.67E-3 HLA-DRB1, HLA-DQB1, 
GATA3, IL18R1, MICA 
Regulation of interleukin-4 production 3 3.67E-3 HLA-DRB1, IL33, GATA3 
Response to other organism 8 3.67E-3 HLA-DRB1, HLA-A, GATA3, 
SMAD3, RNF5, PDE4D, IL6R, 
MICA 
Positive regulation of T cell mediated cytotoxicity 3 3.67E-3 HLA-DRB1, HLA-DQB1, HLA-
C 
Leukocyte mediated immunity 5 3.67E-3 HLA-DRB1, HLA-DQB1, 
GATA3, IL6R, MICA 
Antigen processing and presentation of 
endogenous peptide antigen via MHC class I via 
ER pathway, TAP-independent 
2 3.67E-3 HLA-A, HLA-C 
Antigen processing and presentation of 
exogenous peptide antigen 
5 4.60E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, HLA-C 
Response to biotic stimulus 8 4.60E-3 HLA-DRB1, HLA-A, RNF5, 
GATA3, SMAD3, PDE4D, 
MICA, IL6R 
Regulation of cytokine production 7 4.75E-3 HLA-DPB1, HLA-DRB1, HLA-
A, IL1RL1, IL18R1, PDE4D, 
IL6R 
Regulation of T cell mediated cytotoxicity 3 4.75E-3 HLA-DRB1, HLA-DQB1, HLA-
C 
Antigen processing and presentation of 
exogenous antigen 
5 4.96E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-C, HLA-A 
Positive regulation of T cell activation 5 4.96E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, GATA3  
Positive regulation of leukocyte cell-cell 
adhesion 
5 5.11E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, GATA3  
Positive regulation of homotypic cell-cell 
adhesion 
5 5.13E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, GATA3  
Negative regulation of cytokine production 5 5.73E-3 HLA-DRB1, IL33, IL1RL1, 
GATA3, IL6R 
Regulation of lymphocyte activation 6 6.80E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, IKZF3, MICA 
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Regulation of lymphocyte mediated immunity 4 9.17E-3 HLA-DRB1, HLA-DQB1, HLA-
C, MICA 
Positive regulation of cell-cell adhesion 5 9.91E-3 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, GATA3 
Positive regulation of T cell mediated immunity 3 1.05E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Positive regulation of immune response 7 1.05E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-C, IL33, GATA3, 
PDE4D 
Positive regulation of chemokine production 3 1.16E-2 IL33, IL1RL1, IL6R 
Positive regulation of leukocyte mediated 
cytotoxicity 
3 1.16E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Negative regulation of T-helper 1 type immune 
response 
2 1.21E-2 IL33, IL1RL1 
Antigen processing and presentation of 
endogenous peptide antigen via MHC class I via 
ER pathway 
2 1.21E-2 HLA-C, HLA-A 
Positive regulation of immune system process 8 1.29E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1, IL1RL1, GATA3, 
PDE4D, IL6R 
Regulation of cytokine secretion 4 1.33E-2 HLA-DRB1, IL33, IL1RL1 
GATA3 
Positive regulation of lymphocyte activation 5 1.35E-2 HLA-DPB1, HLA-DRBQ, HLA-
DQB1, HLA-A, GATA3 
Regulation of defense response 7 1.35E-2 HLA-DRB1, HLA-A, IL33, 
IL1RL1, GATA3, SMAD3, 
MICA 
Lymphocyte mediated immunity 4 1.35E-2 HLA-DRB1, HLA-DQB1, 
GATA3, MICA 
Regulation of inflammatory response 5 1.36E-2 HLA-DRB1, IL33, IL1RL1, 
GATA3, SMAD3 
Positive regulation of cell killing 3 1.43E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Cellular response to organic substance 11 1.44E-2 HLA-DPB1, HLA-DRBQ, HLA-
DQB1, HLA-A, HLA-C, IL1RL1, 
GATA3, IL18R1, IL2RB, RNF5, 
ATP6V1G2 
Immune effector process 6 1.60E-2 HLA-DRB1, HLA-DQB1, 
GATA3, IL1RL1, IL6R, MICA 
Response to bacterium 6 1.75E-2 HLA-DRB1, HLA-A, RNF5, 
PDE4D, IL6R, MICA 
Regulation of T cell mediated immunity 3 1.75E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Positive regulation of chemokine secretion 2 1.75E-2 IL33, IL1RL1 
Negative regulation of natural killer cell mediated 
immunity 
2 1.75E-2 HLA-A, MICA 
Positive regulation of interleukin-13 production 2 1.75E-2 IL33, GATA3 
Negative regulation of natural killer cell mediated 
cytotoxicity 
2 1.75E-2 HLA-A, MICA 
Regulation of leukocyte mediated immunity 4 1.81E-2 HLA-DRB1, HLA-DQB1, HLA-
C, MICA 
Regulation of chemokine production 3 2.03E-2 IL33-IL1RL1, IL6R 




Positive regulation of immune effector process 4 2.04E-2 HLA-DRB1, HLA-DQB1, HLA-
A, IL33 
Regulation of chemokine secretion 2 2.04E-2 IL33, IL1RL1 
Type 2 immune response 2 2.04E-2 IL33, GATA3 
Antigen processing and presentation of 
exogenous peptide antigen via MHC class I, 
TAP-independent 
2 2.04E-2 HLA-A, HLA-C 
Regulation of immune effector process 5 2.07E-2 HLA-DRB1, HLA-DQB1, HLA-
C, IL33, MICA 
Immune response-activating cell surface 
receptor signaling pathway 
5 2.08E-2 HLA-DRB1, HLA,-DRB1, HLA-
DQB1, GATA3, PDE4D 
Regulation of immune system process 9 2.31E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1, IL1RL1, SMAD3, 
IKZF3, PDE4D, IL6R, MICA 
Positive regulation of macrophage activation 2 2.39E-2 IL33, IL1RL1 
Negative regulation of leukocyte mediated 
cytotoxicity 
2 2.39E-2 HLA-A, MICA 
Antigen processing and presentation of 
endogenous peptide antigen via MHC class I 
2 2.88E-2 HLA-C, HLA-A 
Lymphocyte activation 5 2.91E-2 GATA3, SMAD3, IL18R1, 
IKZF3, MICA 
Negative regulation of immune system process 5 3.29E-2 HLA-DRB1, HLA-A, IL33, 
IL1RL1, MICA 
Negative regulation of cell killing 2 3.29E-2 HLA-A, MICA 
Antigen processing and presentation of 
endogenous peptide antigen 
2 3.29E-2 HLA-C, HLA-A 
Regulation of lymphocyte proliferation 4 3.67E-2 HLA-DPB1, HLA-DRB1, HLA-
A, IKZF3 
Regulation of mononuclear cell proliferation 4 3.71E-2 HLA-DPB1, HLA-DRB1, HLA-
A, IKZF3 
Regulation of interleukin-13 production 2 3.75E-2 IL33, GATA3 
Positive regulation of lymphocyte mediated 
immunity 
3 3.97E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Regulation of leukocyte proliferation 4 4.05E-2 HLA-DPB1, HLA-DRB1, HLA-
A, IKZF3 
Positive regulation of adaptive immune response 
based on somatic recombination of immune 
receptors built from immunoglobulin superfamily 
domains 
3 4.05E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Antigen processing and presentation of 
endogenous antigen 
2 4.05E-2 HLA-C, HLA-A 
T-helper 1 type immune response 2 4.05E-2 HLA-DRB1, IL18R1 
Detection of bacterium 2 4.05E-2 HLA-DRB1, HLA-A 
Regulation of response to wounding 5 4.05E-2 HLA-DRB1, IL33, IL1RL1, 
GATA3, SMAD3 
Positive regulation of adaptive immune response 3 4.35E-2 HLA-DRB1, HLA-DQB1, HLA-
C 
Positive regulation of cytokine secretion 3 4.46E-2 IL33, IL1RL1, GATA3  
Regulation of cell adhesion 6 4.46E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-A, SMAD3, 
ABI3BP 
Detection of other organism 2 4.47E-2 HLA-DRB1, HLA-A 
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T cell costimulation 3 4.70E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1 
Lymphocyte costimulation 3 4.84E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1 
Positive regulation of interleukin-4 production 2 4.96E-2 IL33, GATA3 
Cellular response to chemical stimulus 11 5.16E-2 HLA-DPB1, HLA-DRB1, HLA-
DQB1, HLA-C, HLA-A, IL18R1, 
IL2RB, RNF5, IL1RL1, GATA3, 
ATP6V1G2 
*P-values are FDR corrected    
 
B: 
Kegg pathway Number 
of genes 
P-value* Gene 
Allograft rejection 5 7.59E-7 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Graft-versus-host disease 5 7.59E-7 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Type I diabetes mellitus 5 8.78E-7 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Autoimmune thyroid disease 5 1.89E-6 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Viral myocarditis 5 2.73E-6 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Inflammatory bowel disease (IBD) 5 4.20E-6 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 GATA3, IL18R1 
Antigen processing and presentation 5 4.94E-6 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Phagosome 6 7.03E-6 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A, 
TUBB 
Cell adhesion molecules (CAMs) 5 1.41E-4 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
HTLV-I infection 6 1.52E-4 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A, 
IL2RB 
Herpes simplex infection 5 3.83E-4 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Asthma 3 4.14E-4 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
Epstein-Barr virus infection 5 4.83E-4 HLA-DPB1, HLA-DRB1, 
HLA-DQB1, HLA-C, HLA-A 
Intestinal immune network for IgA 
production 
3 1.41E-3 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
Staphylococcus aureus infection 3 2.04E-3 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 




Leishmaniasis 3 4.44E-3 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
Rheumatoid arthritis 3 7.74E-3 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
Systemic lupus erythematosus 3 9.85E-3 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
Toxoplasmosis 3 1.56E-2 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
Cytokine-cytokine receptor interaction 4 1.65E-2 IL18R1, IL2RB, TSLP, IL6R 
Natural killer cell mediated cytotoxicity 3 1.85E-2 HLA-C, HLA-A, MICA 
Jak-STAT signaling pathway 3 3.36E-2 IL2RB, TSLP, IL6R 
Tuberculosis 3 4.26E-2 HLA-DPB1, HLA-DRB1, 
HLA-DQB1 
*P-values are FDR corrected    
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Supplementary table E12: All asthma associated SNPs (p≤10-4 fixed effects) in the DAG cohort and meta-analysis. P; p-value fixed effect, P(R); 
p-value random effect, OR; Odds Ratio fixed effect, OR(R); Odds ratio random effect, I; I² statistic describes the percentage of variation across 
studies that is due to heterogeneity rather than chance  
 
 
    
DAG Cohort Meta-analysis 
CHR BP SNP A1 P P(R) OR OR(R) I 
Included 
cohorts (n) P P(R) OR OR(R) I 
1 30258715 rs374904 T 4.23E-04 4.23E-04 0.68 0.68 0 3 1.22E-02 1.85E-01 0.80 0.80 70 
1 30409346 rs12142410 G 9.93E-05 1.73E-03 0.72 0.72 35 3 1.81E-05 3.68E-05 0.75 0.75 7 
1 43539725 rs7527092 A 8.02E-04 3.66E-02 1.25 1.25 62 3 2.91E-04 3.74E-03 1.21 1.21 37 
1 47837606 rs12742768 G 4.56E-04 4.56E-04 1.47 1.47 0 3 5.48E-03 6.67E-02 1.27 1.28 58 
1 48466846 rs764656 C 5.72E-04 5.72E-04 1.33 1.33 0 3 9.49E-03 1.08E-01 1.19 1.19 63 
1 55746074 rs1695941 A 6.69E-04 6.69E-04 1.29 1.29 0 3 8.22E-03 7.29E-02 1.17 1.17 57 
1 63867699 rs855314 G 5.85E-05 3.47E-04 0.69 0.69 21 3 2.68E-03 1.25E-01 0.80 0.79 76 
1 81429313 rs4120877 T 7.04E-04 7.04E-04 1.33 1.33 0 3 5.82E-04 5.89E-04 1.26 1.26 0 
1 81440903 rs2225966 G 5.27E-04 5.27E-04 1.27 1.27 0 3 6.53E-04 6.53E-04 1.20 1.20 0 
1 99222557 rs12084355 C 3.10E-04 3.26E-02 0.75 0.74 67 3 4.03E-04 1.71E-02 0.79 0.79 57 
1 188918156 rs10753952 T 9.79E-04 9.79E-04 0.79 0.79 0 3 9.52E-03 7.80E-02 0.86 0.86 56 
1 188930912 rs10920778 T 8.13E-04 8.13E-04 0.79 0.79 0 3 7.70E-03 7.43E-02 0.86 0.85 57 
1 233827440 rs10926189 T 4.90E-04 1.18E-03 0.78 0.78 14 3 2.87E-02 2.75E-01 0.88 0.87 79 
2 15812394 rs10204448 A 5.97E-04 5.97E-04 0.62 0.62 0 3 4.42E-03 4.72E-02 0.73 0.73 52 
2 20600243 rs10167494 T 8.32E-05 8.06E-04 0.76 0.76 27 3 1.55E-04 5.13E-03 0.82 0.81 47 
2 24917697 rs2241759 G 1.32E-04 1.32E-04 0.78 0.78 0 3 1.26E-02 2.26E-01 0.88 0.87 79 
2 43756570 rs3828297 A 7.31E-04 7.31E-04 1.28 1.28 0 3 1.57E-03 4.17E-03 1.20 1.20 19 
2 50128278 rs1037426 C 4.86E-04 4.86E-04 0.79 0.79 0 5 1.15E-03 6.24E-03 0.88 0.88 37 
2 50128582 rs3861561 G 3.28E-04 3.28E-04 0.78 0.78 0 3 3.40E-05 3.40E-05 0.80 0.80 0 
2 76235569 rs12618337 C 3.01E-04 3.01E-04 1.58 1.58 0 3 1.78E-02 2.04E-01 1.26 1.30 77 
2 76259467 rs1608590 T 1.59E-04 1.59E-04 1.56 1.56 0 3 6.01E-03 1.41E-01 1.29 1.32 75 
2 76407585 rs1526611 A 1.54E-04 1.54E-04 1.49 1.49 0 3 5.49E-03 1.21E-01 1.27 1.28 71 
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2 106806735 rs7607147 C 7.38E-04 7.38E-04 0.64 0.64 0 3 8.92E-03 8.89E-02 0.76 0.76 57 
2 106874134 rs6709151 C 6.25E-04 6.25E-04 0.71 0.71 0 3 6.31E-03 7.30E-02 0.80 0.80 60 
2 126996061 rs1440049 T 4.16E-04 4.16E-04 1.40 1.40 0 3 6.86E-05 6.86E-05 1.35 1.35 0 
2 127173938 rs17014263 G 5.86E-04 9.95E-03 1.49 1.49 44 3 9.73E-03 1.18E-01 1.25 1.29 71 
2 128975785 rs7583856 G 7.85E-04 7.85E-04 1.34 1.34 0 3 1.02E-03 1.02E-03 1.25 1.25 0 
2 141289053 rs6749275 C 6.27E-05 6.27E-05 1.30 1.30 0 3 6.68E-04 2.55E-02 1.20 1.20 59 
2 167793103 rs7602119 T 2.29E-04 2.29E-04 0.72 0.72 0 3 9.63E-04 8.61E-03 0.79 0.79 37 
2 167807984 rs10497323 C 5.29E-04 5.29E-04 0.73 0.73 0 3 1.17E-03 2.16E-03 0.79 0.79 11 
2 173767653 rs3769165 C 8.10E-04 8.10E-04 1.31 1.31 0 3 3.02E-03 1.28E-02 1.21 1.21 30 
2 205524087 rs6435265 T 3.10E-04 3.10E-04 1.28 1.28 0 3 5.11E-05 5.11E-05 1.25 1.25 0 
2 210940277 rs10932328 C 1.96E-04 1.96E-04 1.34 1.34 0 3 1.49E-03 2.29E-02 1.22 1.23 50 
2 215247415 rs6727011 T 5.49E-04 1.51E-02 0.62 0.63 45 3 2.54E-01 8.78E-01 0.87 0.94 91 
2 217132354 rs12463731 T 6.20E-04 6.20E-04 0.79 0.79 0 3 2.12E-02 1.71E-01 0.88 0.87 70 
2 217530158 rs1921987 A 5.33E-04 5.33E-04 0.79 0.79 0 3 9.19E-04 9.19E-04 0.84 0.84 0 
2 221931479 rs1897121 A 6.87E-04 6.87E-04 1.27 1.27 0 3 8.47E-02 4.27E-01 1.10 1.11 82 
2 226190916 rs1431086 A 1.98E-04 1.98E-04 1.48 1.48 0 3 9.26E-03 1.48E-01 1.24 1.26 73 
2 226225481 rs4641920 C 9.83E-04 9.83E-04 1.32 1.32 0 3 5.61E-02 3.01E-01 1.14 1.15 77 
2 239995931 rs843451 G 6.55E-04 1.23E-02 0.78 0.78 46 3 3.89E-03 6.47E-02 0.84 0.84 62 
3 2689759 rs10510237 A 9.83E-04 9.83E-04 1.44 1.44 0 3 2.38E-02 1.88E-01 1.21 1.23 71 
3 13165384 rs9864101 C 3.00E-04 2.94E-02 0.78 0.78 64 3 1.88E-03 7.09E-02 0.85 0.84 69 
3 22457093 rs10510529 T 3.52E-04 3.52E-04 1.39 1.39 0 3 3.60E-02 3.22E-01 1.16 1.18 80 
3 31900672 rs4438696 A 6.78E-04 6.78E-04 1.27 1.27 0 3 2.93E-02 2.29E-01 1.13 1.14 74 
3 43358645 rs7621298 A 4.95E-04 4.95E-04 1.26 1.26 0 3 3.33E-02 2.72E-01 1.12 1.13 77 
3 43643180 rs9852783 T 6.92E-04 1.87E-02 1.26 1.25 51 3 3.12E-02 2.96E-01 1.12 1.13 79 
3 43801826 rs4682696 C 7.90E-04 7.90E-04 0.80 0.80 0 3 5.35E-02 3.21E-01 0.90 0.89 78 
3 54441305 rs9818236 C 5.25E-04 9.28E-04 0.75 0.75 9 3 3.78E-03 5.37E-02 0.83 0.82 58 
3 56771220 rs9825368 T 6.90E-04 6.90E-04 0.70 0.70 0 5 4.01E-03 3.65E-02 0.84 0.81 59 
3 59517436 rs958241 C 7.47E-04 7.47E-04 1.30 1.30 0 3 6.00E-02 3.68E-01 1.12 1.13 80 
3 67177936 rs13086581 T 8.79E-04 8.79E-04 0.67 0.67 0 3 4.72E-02 3.02E-01 0.83 0.82 77 
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3 68204481 rs6548962 C 3.51E-04 3.51E-04 1.27 1.27 0 3 3.65E-04 3.65E-04 1.21 1.21 0 
3 68206421 rs7610023 C 4.62E-05 8.97E-05 1.32 1.32 8 3 1.32E-04 5.97E-03 1.23 1.23 51 
3 68231965 rs6548984 C 2.22E-04 2.22E-04 1.28 1.28 0 3 1.47E-04 1.56E-04 1.22 1.22 1 
3 68267702 rs6768632 T 1.11E-05 1.11E-05 1.34 1.34 0 3 3.46E-05 1.58E-03 1.25 1.25 43 
3 68270600 rs6776172 G 2.23E-05 2.23E-05 1.38 1.38 0 3 2.39E-03 1.39E-01 1.20 1.21 78 
3 79572661 rs4535189 G 9.64E-04 9.64E-04 0.81 0.81 0 3 5.86E-03 3.05E-02 0.87 0.86 40 
3 96078762 rs7613024 A 9.66E-04 2.91E-03 1.61 1.62 19 3 8.72E-03 8.30E-02 1.34 1.38 62 
3 96346161 rs4407407 C 3.29E-04 4.02E-02 1.65 1.67 69 3 1.15E-03 4.87E-02 1.43 1.46 67 
3 96475398 rs6806336 A 6.60E-04 4.27E-02 1.61 1.62 66 3 1.28E-03 3.30E-02 1.43 1.45 59 
3 102098240 rs2245556 T 3.51E-04 3.51E-04 0.70 0.70 0 3 2.54E-03 2.30E-02 0.79 0.78 48 
3 102114269 rs2252229 C 1.83E-04 1.83E-04 0.78 0.78 0 3 1.63E-02 2.25E-01 0.88 0.87 78 
3 102172552 rs10511181 G 8.43E-04 8.43E-04 0.71 0.71 0 3 6.75E-03 4.07E-02 0.81 0.80 48 
3 102212341 rs1449302 C 2.91E-04 2.91E-04 0.79 0.79 0 5 1.56E-05 1.57E-04 0.88 0.87 28 
3 102220701 rs13091963 A 1.95E-04 1.40E-01 0.76 0.76 85 5 1.77E-05 2.90E-03 0.87 0.85 58 
3 105681807 rs2263357 G 8.46E-04 2.35E-02 0.75 0.75 53 3 4.78E-02 3.22E-01 0.88 0.86 81 
3 128745447 rs2594210 A 9.88E-06 9.88E-06 0.74 0.74 0 3 1.74E-04 2.36E-02 0.82 0.81 66 
3 128775478 rs4974445 C 1.45E-05 1.45E-05 0.72 0.72 0 3 8.64E-04 7.81E-02 0.82 0.81 74 
3 128834182 rs13082666 T 4.58E-06 4.58E-06 0.73 0.73 0 3 9.17E-04 1.35E-01 0.83 0.83 81 
3 168159533 rs7613166 G 4.57E-04 8.55E-04 0.75 0.75 10 3 5.63E-03 8.73E-02 0.83 0.83 65 
3 179671802 rs13075114 G 4.56E-04 4.56E-04 1.33 1.33 0 3 2.64E-04 2.64E-04 1.27 1.27 0 
4 5614097 rs13113867 A 8.84E-04 8.84E-04 1.26 1.26 0 3 5.01E-03 4.36E-02 1.16 1.17 52 
4 7413908 rs10937807 A 1.60E-06 1.66E-04 0.72 0.72 38 3 1.20E-06 5.06E-04 0.77 0.77 50 
4 16199686 rs11945652 A 9.11E-04 3.78E-03 1.29 1.29 23 3 4.37E-03 4.88E-02 1.19 1.19 53 
4 17890573 rs10488992 A 8.83E-04 7.54E-03 1.32 1.32 34 3 2.28E-03 2.44E-02 1.23 1.23 46 
4 66459835 rs7660970 G 5.50E-04 5.50E-04 0.78 0.78 0 3 6.43E-02 3.65E-01 0.90 0.89 81 
4 70627379 rs2292092 T 3.47E-04 3.47E-04 0.78 0.78 0 3 1.48E-03 1.85E-02 0.84 0.84 47 
4 70633662 rs1847366 T 3.47E-04 3.47E-04 0.78 0.78 0 3 1.76E-03 2.43E-02 0.84 0.84 50 
4 77793218 rs7656480 G 3.57E-04 3.57E-04 1.30 1.30 0 3 6.53E-03 1.09E-01 1.17 1.18 67 
4 77797774 rs903044 G 7.37E-04 7.37E-04 1.29 1.29 0 3 1.75E-02 1.82E-01 1.15 1.16 71 
33 
 
4 77808983 rs7691621 G 7.05E-04 7.05E-04 1.29 1.29 0 3 1.51E-02 1.49E-01 1.16 1.16 67 
4 113537032 rs2351458 C 8.06E-04 2.76E-02 0.80 0.80 57 3 1.60E-02 2.13E-01 0.88 0.88 75 
4 125125707 rs908822 T 5.80E-04 5.80E-04 0.60 0.60 0 3 1.77E-04 1.77E-04 0.65 0.65 0 
4 151450821 rs1813134 T 2.44E-04 1.16E-03 0.77 0.77 22 3 7.40E-04 1.39E-02 0.83 0.83 48 
4 151457886 rs962626 T 1.83E-04 3.94E-04 0.77 0.77 10 3 7.08E-04 1.59E-02 0.83 0.82 50 
4 164177106 rs4132177 A 1.27E-04 1.36E-03 1.79 1.79 30 4 1.37E-05 1.47E-03 1.45 1.47 42 
4 182564832 rs724658 A 9.27E-04 9.27E-04 1.30 1.30 0 3 8.63E-03 6.30E-02 1.18 1.18 51 
5 3182592 rs17551573 A 7.52E-05 2.43E-02 0.64 0.64 66 3 1.90E-02 3.11E-01 0.82 0.79 86 
5 4830480 rs10069581 A 8.03E-04 8.03E-04 0.68 0.68 0 3 2.43E-03 1.33E-02 0.75 0.75 34 
5 7938959 rs162036 G 6.79E-04 6.79E-04 1.42 1.42 0 3 2.88E-02 2.57E-01 1.20 1.21 76 
5 28061691 rs7710236 T 3.28E-04 3.28E-04 1.32 1.32 0 3 4.93E-03 8.11E-02 1.19 1.19 63 
5 29285301 rs7717683 G 3.01E-04 3.01E-04 0.72 0.72 0 3 6.37E-04 2.24E-03 0.78 0.77 21 
5 29403231 rs7717780 T 1.51E-04 1.79E-03 0.76 0.76 32 3 2.13E-03 7.67E-02 0.84 0.83 69 
5 41608479 rs589757 A 8.80E-04 2.32E-02 0.76 0.76 54 3 1.06E-04 3.77E-04 0.78 0.78 16 
5 62499530 rs601429 C 8.22E-04 8.22E-04 1.26 1.26 0 3 5.37E-02 3.30E-01 1.11 1.12 78 
5 71723979 rs13158670 A 7.20E-04 7.20E-04 1.25 1.25 0 3 1.97E-02 1.70E-01 1.13 1.14 69 
5 82983972 rs2045380 G 7.54E-04 7.54E-04 0.73 0.73 0 3 2.23E-02 2.65E-01 0.84 0.85 73 
5 96559225 rs1000083 T 2.45E-04 2.45E-04 0.63 0.63 0 3 2.67E-03 5.69E-02 0.75 0.74 62 
5 96766902 rs291805 A 2.18E-04 2.18E-04 0.58 0.58 0 3 2.86E-03 4.86E-02 0.72 0.70 62 
5 115212349 rs26529 C 4.19E-04 4.19E-04 0.78 0.78 0 3 2.35E-03 1.73E-02 0.84 0.84 40 
5 127028777 rs711363 C 4.50E-04 2.25E-03 1.30 1.30 25 3 1.40E-04 1.44E-04 1.25 1.25 0 
5 127076410 rs1213745 G 2.71E-04 4.96E-03 1.32 1.32 41 3 1.89E-04 2.01E-03 1.25 1.25 33 
5 127163508 rs1616107 G 2.42E-04 2.42E-04 1.32 1.32 0 3 3.03E-05 3.03E-05 1.28 1.28 0 
5 127175702 rs790479 C 9.91E-04 9.91E-04 1.27 1.27 0 3 1.51E-04 1.51E-04 1.25 1.25 0 
5 145700624 rs891970 T 3.44E-04 3.44E-04 0.76 0.76 0 3 3.72E-03 5.59E-02 0.83 0.83 58 
5 155007766 rs2552979 C 5.25E-04 1.51E-02 0.76 0.76 52 3 1.03E-02 1.54E-01 0.85 0.84 74 
5 170167299 rs10063254 T 8.62E-04 8.62E-04 1.29 1.29 0 3 9.09E-02 4.21E-01 1.11 1.12 82 
5 172075156 rs12657303 A 2.99E-04 2.99E-04 0.78 0.78 0 3 1.90E-02 2.19E-01 0.88 0.87 76 
6 6674737 rs6924289 C 1.71E-04 1.74E-02 1.44 1.44 60 3 2.64E-05 6.40E-04 1.38 1.38 35 
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6 6675511 rs201061 A 9.77E-04 8.95E-02 1.24 1.24 73 3 4.40E-03 1.11E-01 1.16 1.16 70 
6 18180845 rs10456820 T 8.43E-04 1.11E-02 0.76 0.76 42 3 1.92E-02 2.08E-01 0.86 0.85 74 
6 20345022 rs717208 A 8.92E-04 8.92E-04 0.80 0.80 0 3 1.11E-02 9.79E-02 0.88 0.87 61 
6 20632361 rs761154 A 1.34E-05 6.85E-04 0.75 0.75 39 5 3.63E-03 1.12E-01 0.90 0.89 75 
6 20641141 rs6909467 T 4.88E-04 4.88E-04 0.78 0.78 0 3 4.29E-03 4.17E-02 0.85 0.84 52 
6 20674435 rs6918457 G 1.13E-04 1.13E-04 0.73 0.73 0 3 4.28E-03 1.09E-01 0.84 0.82 73 
6 24202119 rs2176933 A 6.81E-04 5.76E-02 1.45 1.45 69 3 2.83E-02 3.27E-01 1.21 1.22 81 
6 31463297 rs2596560 C 7.41E-04 7.41E-04 1.27 1.27 0 5 2.13E-05 2.13E-05 1.20 1.20 0 
6 32255739 rs3134943 T 9.93E-04 9.93E-04 0.74 0.74 0 3 1.97E-03 1.97E-03 0.79 0.79 0 
6 32295001 rs394657 G 3.01E-04 3.01E-04 1.27 1.27 0 5 1.40E-03 9.69E-03 1.10 1.13 60 
6 32296361 rs422951 C 9.50E-04 9.50E-04 1.24 1.24 0 3 3.57E-04 3.57E-04 1.20 1.20 0 
6 32298006 rs3132946 A 9.36E-04 9.36E-04 0.73 0.73 0 3 2.13E-03 2.13E-03 0.79 0.79 0 
6 45651316 rs2280229 T 2.80E-04 2.80E-04 0.78 0.78 0 3 7.18E-03 1.11E-01 0.86 0.86 68 
6 45671713 rs7742046 A 7.46E-04 1.51E-01 1.32 1.32 82 3 1.08E-04 2.19E-02 1.28 1.28 65 
6 66898096 rs9354380 A 8.88E-04 8.88E-04 1.33 1.33 0 3 3.09E-04 3.09E-04 1.28 1.28 0 
6 75114909 rs6936857 G 4.26E-04 6.52E-04 0.77 0.77 6 3 2.42E-02 2.46E-01 0.88 0.87 78 
6 88031086 rs9353470 A 8.07E-05 8.68E-02 0.66 0.68 78 3 2.26E-04 6.37E-02 0.73 0.74 72 
6 113823263 rs6568783 T 2.84E-06 1.21E-02 0.59 0.58 72 3 1.05E-03 1.69E-01 0.75 0.72 87 
6 113862599 rs909543 A 3.57E-06 3.57E-06 0.63 0.63 0 3 3.35E-04 7.74E-02 0.76 0.74 79 
6 140232551 rs9484321 T 9.39E-04 5.82E-03 1.25 1.25 31 3 4.06E-03 4.34E-02 1.16 1.17 54 
6 140243368 rs7760148 A 2.12E-04 2.12E-04 1.29 1.29 0 3 1.45E-02 1.99E-01 1.14 1.16 77 
6 144066988 rs7739094 T 9.75E-04 9.75E-04 1.26 1.26 0 3 7.43E-03 4.36E-02 1.16 1.16 47 
6 144078630 rs761627 G 2.81E-04 1.96E-03 1.27 1.27 27 3 1.07E-02 1.76E-01 1.14 1.15 76 
6 157503677 rs1007250 A 3.97E-04 2.66E-03 0.74 0.74 28 3 1.75E-02 2.00E-01 0.86 0.84 77 
6 158281887 rs912879 C 9.43E-04 9.43E-04 0.77 0.77 0 3 1.00E-01 4.28E-01 0.90 0.89 82 
6 161481246 rs1807426 T 5.71E-04 1.12E-02 1.66 1.69 48 3 6.26E-02 2.98E-01 1.23 1.33 83 
7 19443464 rs7811056 G 9.22E-04 9.22E-04 1.24 1.24 0 3 4.82E-03 2.20E-02 1.16 1.16 36 
7 55105882 rs10488140 T 2.71E-04 2.71E-04 1.34 1.34 0 3 3.38E-02 3.37E-01 1.15 1.16 82 
7 57474574 rs9642239 T 9.09E-04 9.09E-04 0.79 0.79 0 3 5.43E-03 2.91E-02 0.85 0.85 41 
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7 76679195 rs10488500 G 4.25E-04 4.25E-04 1.47 1.47 0 3 8.40E-03 8.51E-02 1.25 1.27 64 
7 86891086 rs31667 A 2.72E-04 2.70E-03 1.44 1.44 33 3 2.78E-02 2.66E-01 1.19 1.22 82 
7 97974246 rs817921 C 5.56E-04 6.23E-02 0.78 0.78 72 3 1.04E-04 5.08E-03 0.80 0.80 49 
7 103153828 rs563264 G 1.79E-04 1.79E-04 0.70 0.70 0 3 1.03E-03 1.31E-02 0.78 0.78 43 
7 105124158 rs2075114 T 3.51E-04 3.51E-04 0.60 0.60 0 3 6.03E-02 3.75E-01 0.81 0.79 83 
7 106232810 rs10262903 A 4.02E-04 4.02E-04 1.29 1.29 0 3 2.59E-02 2.19E-01 1.13 1.15 76 
7 124168925 rs1544452 C 4.83E-04 4.83E-04 1.30 1.30 0 3 8.51E-03 1.03E-01 1.17 1.17 64 
7 128157600 rs750464 T 7.85E-04 8.24E-03 1.74 1.73 37 3 3.22E-02 2.34E-01 1.31 1.37 77 
7 150051637 rs3735078 G 8.02E-04 8.02E-04 0.67 0.67 0 3 7.31E-04 7.31E-04 0.73 0.73 0 
7 151851010 rs10248875 T 7.44E-04 7.44E-04 0.80 0.80 0 3 3.31E-02 2.37E-01 0.89 0.89 74 
7 152382419 rs2037929 G 7.83E-04 7.83E-04 0.76 0.76 0 3 2.56E-02 1.86E-01 0.87 0.86 70 
7 152405485 rs626190 G 8.13E-04 1.09E-03 0.71 0.71 5 3 2.95E-02 2.27E-01 0.84 0.82 75 
8 17134884 rs2904698 G 8.31E-04 8.31E-04 1.38 1.38 0 3 1.97E-02 1.89E-01 1.20 1.20 70 
8 17156132 rs7834656 C 5.73E-04 5.73E-04 1.39 1.39 0 3 6.43E-03 6.52E-02 1.23 1.24 57 
8 21287480 rs17497685 T 8.72E-04 8.72E-04 0.67 0.67 0 3 7.38E-02 3.50E-01 0.85 0.82 80 
8 54294966 rs966247 G 6.22E-05 6.22E-05 0.65 0.65 0 3 2.23E-04 8.10E-03 0.73 0.73 51 
8 117017347 rs760297 C 5.76E-04 5.76E-04 0.73 0.73 0 3 7.09E-03 8.18E-02 0.83 0.82 63 
8 129508233 rs6470627 T 9.48E-04 9.48E-04 0.63 0.63 0 3 1.63E-01 5.77E-01 0.85 0.85 86 
8 133227223 rs1864773 A 9.74E-04 4.39E-03 0.73 0.73 26 3 2.56E-02 2.34E-01 0.84 0.84 74 
8 141529043 rs7841423 C 2.24E-04 2.24E-04 1.53 1.53 0 3 6.37E-03 1.23E-01 1.29 1.30 71 
8 142185324 rs925358 A 5.56E-04 9.16E-03 0.73 0.73 43 3 3.24E-02 2.79E-01 0.86 0.84 80 
9 5382199 rs3739636 A 3.52E-04 3.52E-04 0.79 0.79 0 3 2.90E-03 3.33E-02 0.86 0.85 51 
9 5402546 rs10815211 T 7.80E-04 1.15E-01 0.76 0.75 79 3 3.10E-03 1.09E-01 0.83 0.82 73 
9 6118897 rs340908 T 9.17E-04 9.17E-04 0.74 0.74 0 3 1.24E-03 1.42E-03 0.79 0.79 3 
9 6180076 rs1342326 C 6.88E-04 6.88E-04 1.36 1.36 0 3 1.37E-03 3.09E-03 1.25 1.26 16 
9 15576534 rs10810402 T 9.01E-04 9.01E-04 0.80 0.80 0 3 1.59E-03 6.89E-03 0.85 0.85 28 
9 15594746 rs10481557 G 7.65E-04 1.21E-01 0.80 0.80 79 3 1.25E-03 6.67E-02 0.84 0.84 69 
9 15660445 rs6474944 C 7.12E-04 1.02E-01 0.80 0.80 77 3 9.06E-04 4.78E-02 0.84 0.84 66 
9 15695479 rs1396708 A 5.11E-04 9.39E-02 0.79 0.79 77 3 8.59E-04 5.27E-02 0.84 0.83 68 
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9 15743411 rs4740624 C 7.49E-04 5.41E-02 0.80 0.80 68 3 2.04E-03 5.37E-02 0.85 0.85 63 
9 15774631 rs1539172 A 5.04E-04 1.11E-01 0.80 0.79 80 3 6.45E-03 1.84E-01 0.87 0.86 79 
9 15813667 rs7019205 C 3.41E-04 1.11E-02 1.27 1.27 50 3 6.36E-03 1.38E-01 1.15 1.16 73 
9 15815230 rs1009468 G 2.22E-04 1.71E-02 1.28 1.28 59 3 4.92E-03 1.43E-01 1.16 1.17 76 
9 15831937 rs2066292 C 1.45E-04 4.95E-03 1.29 1.29 46 3 9.54E-04 4.15E-02 1.19 1.20 64 
9 15836112 rs4741546 T 1.05E-04 3.35E-02 0.77 0.77 70 3 8.16E-04 7.26E-02 0.84 0.83 73 
9 15851885 rs770191 C 7.13E-04 7.13E-04 1.25 1.25 0 3 1.43E-03 3.88E-03 1.18 1.19 19 
9 15888553 rs1984246 A 3.36E-04 1.17E-03 0.79 0.79 18 3 2.31E-03 4.54E-02 0.85 0.85 59 
9 15890771 rs1891212 A 2.87E-04 1.48E-03 0.78 0.78 23 3 2.16E-03 4.88E-02 0.85 0.84 61 
9 15976487 rs1927699 G 8.78E-04 8.78E-04 1.25 1.25 0 3 3.13E-03 1.20E-02 1.17 1.17 30 
9 16013469 rs1328273 A 1.09E-04 3.50E-02 0.77 0.77 70 3 5.58E-04 5.45E-02 0.83 0.83 71 
9 16020606 rs1328279 G 9.55E-06 5.02E-02 0.75 0.75 80 5 1.03E-04 2.09E-02 0.87 0.86 69 
9 16020960 rs4247294 A 5.80E-06 3.80E-02 0.74 0.74 79 3 2.17E-05 3.40E-02 0.80 0.80 76 
9 16038844 rs10810528 A 6.14E-04 5.09E-02 0.80 0.80 67 3 1.04E-02 1.85E-01 0.88 0.87 76 
9 20645564 rs13290184 T 5.50E-04 5.50E-04 0.56 0.56 0 3 3.33E-02 2.60E-01 0.75 0.73 76 
9 21951866 rs7041637 A 4.35E-04 4.35E-04 0.76 0.76 0 3 3.07E-03 2.48E-02 0.84 0.83 47 
9 27810493 rs7020269 G 2.30E-05 1.06E-03 0.76 0.76 40 5 7.12E-03 9.40E-02 0.91 0.88 74 
9 33614429 rs855523 C 9.22E-04 9.22E-04 0.73 0.73 0 3 4.80E-03 2.76E-02 0.79 0.80 34 
9 84749764 rs7029717 C 9.42E-04 1.21E-02 1.42 1.43 44 3 6.41E-03 8.08E-02 1.26 1.27 62 
9 91902306 rs4744096 T 9.14E-04 9.14E-04 0.73 0.73 0 3 8.58E-04 8.58E-04 0.77 0.77 0 
9 101886451 rs16918878 T 2.35E-04 1.48E-02 1.31 1.31 57 3 1.48E-02 2.42E-01 1.15 1.17 81 
9 106726226 rs2487052 T 6.96E-04 6.96E-04 1.31 1.31 0 3 1.36E-01 5.17E-01 1.10 1.11 85 
9 116394764 rs2274595 G 2.11E-04 2.11E-04 0.57 0.57 0 3 1.16E-04 1.16E-04 0.64 0.64 0 
9 117002347 rs4978627 C 4.98E-04 4.98E-04 0.78 0.78 0 3 1.32E-03 3.08E-03 0.84 0.84 16 
9 121074859 rs17534 C 7.72E-04 7.72E-04 1.27 1.27 0 3 8.35E-03 6.99E-02 1.16 1.16 55 
10 6826051 rs353201 T 1.22E-04 1.81E-02 0.48 0.47 64 3 8.69E-04 5.08E-02 0.61 0.58 70 
10 8685729 rs10905417 C 5.83E-04 6.19E-03 0.80 0.79 37 3 1.72E-02 1.98E-01 0.88 0.87 75 
10 42751362 rs12572458 T 7.74E-04 7.74E-04 0.67 0.67 0 3 3.37E-02 2.42E-01 0.82 0.80 74 
10 49438438 rs2120910 T 1.64E-04 1.64E-04 0.72 0.72 0 3 8.70E-03 1.43E-01 0.84 0.82 74 
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10 49452423 rs10491040 C 7.14E-04 7.14E-04 0.71 0.71 0 3 1.60E-03 2.80E-03 0.79 0.78 11 
10 72194347 rs2688768 G 5.67E-04 5.67E-04 0.75 0.75 0 3 1.49E-04 1.49E-04 0.77 0.77 0 
10 73190834 rs3747868 T 1.51E-04 1.51E-04 1.33 1.33 0 3 8.53E-05 8.53E-05 1.27 1.27 0 
10 78434534 rs1907718 G 5.59E-04 5.59E-04 0.69 0.69 0 3 2.04E-02 1.92E-01 0.82 0.81 72 
10 80478533 rs10824709 T 7.75E-04 7.75E-04 0.79 0.79 0 3 2.57E-02 2.09E-01 0.88 0.88 71 
10 80488288 rs1961130 A 1.67E-04 1.67E-04 0.78 0.78 0 3 5.29E-03 1.08E-01 0.86 0.86 69 
10 80495455 rs1370562 A 1.51E-04 1.51E-04 0.72 0.72 0 3 7.48E-03 1.29E-01 0.84 0.82 73 
10 96698216 rs10509679 A 8.86E-04 8.86E-04 0.75 0.75 0 3 2.92E-02 2.26E-01 0.86 0.85 71 
10 102498567 rs4244341 T 6.68E-04 7.52E-03 1.33 1.32 38 3 3.46E-02 2.96E-01 1.15 1.16 79 
10 124755847 rs9328842 T 1.05E-04 1.01E-02 0.75 0.75 56 3 2.02E-03 9.33E-02 0.84 0.82 74 
10 134579752 rs7096936 G 1.05E-04 1.05E-04 1.30 1.30 0 3 1.37E-03 5.07E-02 1.19 1.19 63 
10 134682390 rs7071996 G 9.22E-05 9.22E-05 1.30 1.30 0 3 1.97E-03 5.79E-02 1.18 1.19 65 
11 11453829 rs3741409 G 4.76E-04 1.24E-02 0.77 0.77 50 3 9.57E-04 1.77E-02 0.83 0.82 51 
11 11464491 rs2403515 C 1.25E-04 1.25E-04 0.68 0.68 0 3 2.99E-05 2.99E-05 0.72 0.72 0 
11 35510369 rs1144589 A 3.73E-04 3.73E-04 1.29 1.29 0 3 4.18E-03 5.39E-02 1.18 1.18 58 
11 37089996 rs7946463 C 5.42E-04 5.42E-04 0.78 0.78 0 5 2.96E-02 1.64E-01 0.91 0.90 70 
11 40713036 rs11036050 A 8.85E-04 8.85E-04 0.80 0.80 0 3 9.80E-04 9.80E-04 0.84 0.84 0 
11 44737501 rs1665150 G 6.12E-04 6.12E-04 0.75 0.75 0 3 4.47E-03 4.95E-02 0.83 0.82 57 
11 83115362 rs7111226 T 7.04E-04 7.04E-04 1.29 1.29 0 3 2.77E-03 1.12E-02 1.19 1.20 30 
11 85036902 rs2290823 G 9.48E-04 9.48E-04 0.69 0.69 0 3 4.18E-02 2.35E-01 0.84 0.81 74 
11 94027733 rs11020874 T 2.59E-04 2.59E-04 1.30 1.30 0 3 4.56E-04 6.72E-04 1.22 1.22 6 
11 98834366 rs1910710 G 2.41E-04 2.41E-04 1.28 1.28 0 3 8.44E-03 1.30E-01 1.15 1.16 71 
11 98888063 rs11220245 G 7.92E-04 7.92E-04 1.29 1.29 0 3 1.02E-02 8.41E-02 1.17 1.17 58 
11 111511149 rs243908 G 7.16E-04 7.16E-04 1.26 1.26 0 3 4.05E-02 3.14E-01 1.12 1.13 79 
11 114239611 rs2462169 A 4.89E-04 1.24E-03 0.80 0.80 14 3 1.14E-02 1.78E-01 0.87 0.87 72 
11 114246392 rs7104748 G 3.24E-04 2.33E-03 0.79 0.79 28 3 1.15E-02 2.15E-01 0.88 0.88 76 
11 124242492 rs7102701 C 8.82E-04 8.82E-04 1.25 1.25 0 3 1.37E-02 1.10E-01 1.14 1.15 61 
12 3564728 rs758637 A 4.38E-04 4.38E-04 0.78 0.78 0 3 2.75E-02 2.58E-01 0.89 0.88 78 
12 4303650 rs3885283 A 5.04E-04 1.51E-03 1.29 1.29 17 3 1.74E-02 1.93E-01 1.15 1.16 75 
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12 9705286 rs1108453 G 5.88E-04 5.88E-04 0.73 0.73 0 3 6.35E-04 6.35E-04 0.78 0.78 0 
12 9738400 rs10492164 T 7.64E-04 7.64E-04 0.72 0.72 0 3 1.75E-03 3.46E-03 0.79 0.79 14 
12 14182567 rs11055792 T 3.56E-05 3.56E-05 1.32 1.32 0 3 2.89E-04 1.49E-02 1.21 1.22 57 
12 26364744 rs11614526 C 7.14E-04 1.09E-02 0.79 0.79 43 3 3.32E-03 5.15E-02 0.85 0.85 58 
12 40232806 rs285584 A 8.60E-04 8.60E-04 0.74 0.74 0 3 2.22E-02 1.68E-01 0.85 0.84 68 
12 46630305 rs1015390 T 4.85E-04 4.85E-04 1.43 1.43 0 3 2.61E-02 2.33E-01 1.20 1.21 75 
12 55775976 rs1059513 C 9.83E-04 9.83E-04 0.68 0.68 0 3 2.65E-03 4.84E-03 0.76 0.76 13 
12 72965321 rs1554486 C 9.12E-04 2.17E-03 1.26 1.26 14 3 4.64E-03 4.65E-02 1.17 1.17 53 
12 72968165 rs10128762 G 6.94E-04 8.82E-03 1.26 1.26 40 3 1.06E-02 1.41E-01 1.15 1.16 70 
12 75847095 rs773488 G 3.64E-04 3.64E-04 0.79 0.79 0 3 6.65E-03 9.19E-02 0.87 0.86 65 
12 97027466 rs1811264 C 2.28E-04 2.28E-04 0.76 0.76 0 3 2.89E-03 4.48E-02 0.84 0.83 59 
12 104772017 rs10507202 C 9.61E-04 9.61E-04 1.29 1.29 0 3 2.82E-03 6.64E-03 1.19 1.20 19 
12 118144240 rs1346227 T 7.01E-04 1.28E-01 0.71 0.69 83 3 3.05E-03 1.11E-01 0.80 0.77 77 
13 26421026 rs2149219 A 5.14E-04 1.11E-03 0.74 0.74 12 3 2.38E-02 2.27E-01 0.86 0.84 77 
13 26935566 rs1475221 G 7.78E-04 7.78E-04 0.77 0.77 0 3 2.42E-03 5.91E-03 0.83 0.83 19 
13 71512876 rs2612813 A 5.77E-04 8.06E-03 1.28 1.28 40 3 3.26E-02 3.35E-01 1.13 1.14 80 
13 71517526 rs2706411 T 8.94E-04 5.25E-03 1.27 1.27 29 3 4.18E-02 3.41E-01 1.13 1.13 79 
13 72887581 rs2325510 G 7.30E-04 7.30E-04 1.52 1.52 0 3 1.37E-03 4.68E-03 1.37 1.37 23 
13 76985266 rs1323619 A 3.42E-04 3.42E-04 1.27 1.27 0 3 2.06E-03 3.33E-02 1.18 1.18 54 
13 77078772 rs2274015 C 2.23E-04 2.23E-04 0.78 0.78 0 3 2.69E-03 4.20E-02 0.86 0.85 58 
13 77255783 rs1144383 T 4.65E-04 4.65E-04 1.37 1.37 0 3 1.25E-01 4.95E-01 1.12 1.14 86 
13 84187773 rs6563411 C 7.92E-04 7.92E-04 0.80 0.80 0 3 3.65E-02 2.71E-01 0.90 0.89 75 
13 93718257 rs959390 C 5.88E-04 5.88E-04 1.30 1.30 0 3 1.55E-02 1.56E-01 1.15 1.17 71 
13 105726015 rs9301126 G 3.70E-04 3.97E-04 0.71 0.71 1 3 6.23E-05 6.23E-05 0.74 0.74 0 
13 109697956 rs4145072 C 8.37E-05 3.60E-04 1.29 1.29 18 3 8.20E-03 2.18E-01 1.15 1.16 81 
14 25758820 rs8012418 G 2.96E-04 2.96E-04 1.27 1.27 0 3 3.97E-04 3.97E-04 1.21 1.21 0 
14 25780111 rs1950857 T 7.21E-04 7.21E-04 0.78 0.78 0 3 5.56E-04 5.56E-04 0.82 0.82 0 
14 29054049 rs977122 A 3.15E-04 3.15E-04 1.42 1.42 0 3 6.96E-03 1.09E-01 1.24 1.24 66 
14 43320843 rs1957260 A 1.47E-04 1.47E-04 1.44 1.44 0 3 9.24E-03 1.81E-01 1.22 1.24 76 
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14 43936603 rs12436502 T 4.97E-05 1.50E-01 1.93 1.76 82 3 2.63E-05 4.04E-02 1.83 1.70 67 
14 51522324 rs1253676 G 4.05E-04 4.05E-04 1.30 1.30 0 3 1.33E-02 1.51E-01 1.15 1.17 71 
14 72537512 rs12880210 C 8.88E-04 8.88E-04 0.75 0.75 0 3 2.41E-01 6.11E-01 0.92 0.91 87 
14 83897200 rs12432589 A 7.45E-05 7.45E-05 1.30 1.30 0 3 1.39E-03 4.57E-02 1.18 1.19 64 
14 83969190 rs10138991 G 2.87E-04 2.18E-03 1.28 1.28 29 3 2.48E-03 5.57E-02 1.18 1.19 64 
14 84007010 rs1449104 G 4.62E-04 8.91E-02 0.79 0.79 78 3 8.79E-03 2.18E-01 0.87 0.86 80 
14 89230591 rs8007740 A 1.37E-04 5.10E-02 1.52 1.54 75 3 3.34E-03 1.59E-01 1.29 1.32 80 
15 20499445 rs12594495 G 8.88E-04 8.88E-04 1.27 1.27 0 3 3.13E-03 1.16E-02 1.19 1.19 28 
15 29467308 rs8042404 A 4.53E-04 4.53E-04 1.29 1.29 0 3 2.01E-04 2.01E-04 1.24 1.24 0 
15 58823842 rs9920962 G 6.98E-04 4.69E-02 0.70 0.70 64 3 5.02E-03 1.05E-01 0.79 0.79 69 
15 69323596 rs961577 G 3.62E-04 3.62E-04 0.79 0.79 0 3 2.18E-03 3.31E-02 0.85 0.85 52 
15 69331029 rs4776542 C 2.82E-04 2.82E-04 0.79 0.79 0 3 3.25E-03 7.01E-02 0.86 0.85 63 
15 69332571 rs10518937 T 8.27E-04 8.27E-04 1.25 1.25 0 3 1.80E-03 2.30E-03 1.18 1.18 5 
15 69335278 rs1561884 C 3.12E-05 3.12E-05 1.31 1.31 0 3 4.05E-04 2.93E-02 1.20 1.21 63 
15 69351194 rs10518942 G 3.60E-04 3.60E-04 1.27 1.27 0 3 2.12E-03 1.94E-02 1.18 1.18 44 
15 69358022 rs7173870 T 5.34E-04 5.34E-04 0.80 0.80 0 3 3.96E-03 3.51E-02 0.86 0.86 49 
15 69378393 rs4777363 T 2.35E-04 2.35E-04 1.28 1.28 0 3 3.17E-03 5.01E-02 1.17 1.18 59 
15 69477995 rs10518959 T 8.95E-04 8.95E-04 1.25 1.25 0 3 1.40E-02 1.11E-01 1.14 1.15 61 
15 90522481 rs10520705 G 5.38E-04 5.38E-04 1.59 1.59 0 3 2.71E-02 1.86E-01 1.25 1.30 74 
16 4037223 rs917522 C 4.38E-04 4.38E-04 1.40 1.40 0 3 1.77E-02 2.12E-01 1.20 1.21 74 
16 5743925 rs11866983 A 1.88E-05 1.88E-05 0.74 0.74 0 3 2.29E-04 2.55E-02 0.81 0.80 65 
16 5771031 rs726239 T 8.52E-05 8.52E-05 0.75 0.75 0 3 2.13E-03 6.99E-02 0.83 0.83 68 
16 5775439 rs11076969 T 3.59E-05 3.59E-05 0.74 0.74 0 3 2.65E-04 9.97E-03 0.81 0.81 52 
16 5779288 rs2342735 A 4.59E-04 4.59E-04 0.77 0.77 0 3 1.35E-03 6.00E-03 0.83 0.83 28 
16 5782092 rs4322667 T 9.43E-04 9.43E-04 0.78 0.78 0 3 4.43E-03 1.97E-02 0.84 0.84 34 
16 11625762 rs6498232 C 6.28E-04 6.28E-04 1.36 1.36 0 3 6.62E-04 6.62E-04 1.28 1.28 0 
16 27258188 rs3024530 G 6.14E-04 8.49E-02 1.25 1.25 75 3 1.60E-05 2.25E-03 1.25 1.25 50 
16 30037994 rs11865086 A 7.24E-04 7.24E-04 0.80 0.80 0 3 6.10E-03 5.38E-02 0.86 0.86 54 
16 49495030 rs1395605 T 4.19E-04 7.94E-04 1.26 1.26 10 3 1.13E-02 1.55E-01 1.14 1.15 73 
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16 51379138 rs1420258 G 9.06E-04 9.06E-04 0.80 0.80 0 3 3.19E-04 3.19E-04 0.83 0.83 0 
16 51408972 rs2110830 T 9.36E-04 9.36E-04 0.80 0.80 0 3 1.15E-03 1.15E-03 0.84 0.84 0 
16 51411008 rs2024446 A 9.07E-05 9.07E-05 0.77 0.77 0 3 1.36E-04 4.71E-04 0.82 0.81 17 
16 54295157 rs42460 G 9.76E-04 8.37E-02 1.51 1.51 73 3 3.48E-02 2.68E-01 1.22 1.27 81 
16 56247384 rs1376041 T 3.92E-05 1.61E-04 1.35 1.35 16 3 1.16E-05 4.38E-05 1.29 1.29 14 
16 63319927 rs231053 C 1.62E-04 5.54E-04 1.41 1.41 16 3 2.25E-03 6.25E-02 1.24 1.26 67 
16 63322771 rs231059 A 2.28E-04 7.69E-04 1.40 1.40 17 3 4.28E-03 9.14E-02 1.23 1.25 70 
16 63380873 rs1364218 G 3.66E-04 3.66E-04 1.38 1.38 0 3 3.58E-03 4.93E-02 1.23 1.24 59 
16 71644995 rs4788697 A 2.52E-04 2.52E-04 0.77 0.77 0 3 3.11E-03 6.00E-02 0.84 0.84 61 
16 81008660 rs1025065 T 8.59E-04 8.59E-04 0.80 0.80 0 3 7.91E-03 5.82E-02 0.87 0.86 52 
16 83261468 rs12596786 A 8.52E-04 8.52E-04 1.32 1.32 0 3 1.64E-03 2.02E-03 1.23 1.23 4 
17 7959231 rs3027215 T 9.89E-04 5.57E-03 1.51 1.51 30 3 3.18E-03 2.91E-02 1.33 1.35 49 
17 9649681 rs3843735 G 8.19E-04 8.19E-04 1.25 1.25 0 3 3.89E-02 2.49E-01 1.11 1.13 74 
17 29973811 rs2009472 C 8.25E-04 8.25E-04 0.65 0.65 0 3 1.34E-02 1.02E-01 0.79 0.77 63 
17 34472851 rs4795343 T 1.33E-04 1.33E-04 0.75 0.75 0 3 2.26E-03 6.52E-02 0.83 0.82 67 
17 34483768 rs2091763 C 1.80E-04 3.05E-04 0.75 0.75 7 3 2.48E-03 6.49E-02 0.84 0.83 67 
17 34488719 rs3744077 A 1.37E-04 1.37E-04 0.75 0.75 0 3 2.00E-03 5.72E-02 0.83 0.82 66 
17 35229995 rs9303277 T 8.15E-04 8.15E-04 0.80 0.80 0 4 1.43E-14 1.53E-06 0.76 0.75 57 
17 35282160 rs11557467 T 5.22E-04 5.22E-04 0.80 0.80 0 4 3.29E-15 2.14E-06 0.76 0.75 60 
17 35304874 rs8067378 G 5.88E-04 5.88E-04 0.80 0.80 0 4 3.27E-15 6.15E-06 0.76 0.75 64 
17 35315722 rs2305480 A 1.35E-04 1.35E-04 0.78 0.78 0 5 3.63E-17 1.47E-07 0.78 0.77 60 
17 35319766 rs2290400 C 7.79E-05 7.79E-05 0.77 0.77 0 5 2.55E-20 1.47E-09 0.76 0.76 56 
17 35323475 rs7216389 C 9.71E-05 9.71E-05 0.77 0.77 0 4 2.86E-16 7.79E-06 0.75 0.73 69 
17 35341943 rs4795405 T 1.19E-04 1.19E-04 0.77 0.77 0 5 1.90E-15 1.05E-06 0.79 0.78 64 
17 56778202 rs1990293 A 2.87E-04 2.87E-04 0.74 0.74 0 3 2.66E-03 4.28E-02 0.82 0.81 57 
17 64177801 rs16973217 T 4.57E-06 5.81E-04 1.55 1.54 43 3 4.04E-06 9.07E-04 1.43 1.43 48 
17 64178397 rs9915635 G 3.15E-05 3.15E-05 1.47 1.47 0 5 6.80E-05 1.39E-03 1.23 1.24 37 
17 66891676 rs10512566 A 8.94E-04 8.94E-04 0.79 0.79 0 3 1.36E-02 1.06E-01 0.87 0.87 61 
17 69131303 rs6501655 T 7.98E-04 7.98E-04 0.78 0.78 0 3 9.90E-02 4.49E-01 0.91 0.89 83 
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17 69137515 rs8080253 G 4.74E-05 4.74E-05 0.75 0.75 0 3 1.91E-02 3.14E-01 0.88 0.86 85 
17 69142605 rs8064411 C 6.14E-05 6.14E-05 0.75 0.75 0 3 2.23E-02 3.20E-01 0.88 0.87 85 
17 71297313 rs10221244 G 2.60E-04 2.60E-04 1.28 1.28 0 3 1.82E-02 2.39E-01 1.14 1.14 77 
17 73759725 rs1109279 C 6.00E-04 6.91E-02 0.78 0.78 72 3 3.74E-03 1.10E-01 0.85 0.84 72 
18 986719 rs789056 C 8.99E-04 8.99E-04 1.24 1.24 0 3 1.71E-03 1.71E-03 1.18 1.18 0 
18 10475250 rs518978 G 8.85E-04 8.85E-04 1.24 1.24 0 3 1.70E-02 1.52E-01 1.13 1.14 68 
18 10501302 rs559412 A 8.20E-04 8.20E-04 1.25 1.25 0 3 8.53E-03 6.52E-02 1.15 1.15 54 
18 22703047 rs151245 G 2.14E-04 2.82E-04 1.29 1.29 4 3 9.72E-03 1.77E-01 1.15 1.16 76 
18 27636700 rs567225 T 7.55E-04 1.64E-02 1.25 1.25 50 3 3.12E-02 2.97E-01 1.12 1.13 79 
18 40543599 rs2614999 G 5.47E-04 1.10E-03 0.78 0.78 11 3 4.93E-04 1.54E-03 0.82 0.82 18 
18 40554951 rs11082401 G 5.00E-04 5.00E-04 0.71 0.71 0 3 4.02E-03 3.30E-02 0.80 0.80 49 
18 42389850 rs4581799 A 8.06E-04 2.11E-02 1.32 1.32 53 3 3.32E-02 2.97E-01 1.15 1.16 79 
18 44050037 rs12455475 C 8.16E-04 3.55E-03 1.30 1.30 25 3 3.12E-02 2.37E-01 1.14 1.16 76 
18 46017294 rs11082811 T 3.37E-04 3.37E-04 1.31 1.31 0 3 6.42E-02 3.63E-01 1.11 1.14 83 
18 46023080 rs1790423 C 3.63E-04 3.63E-04 1.30 1.30 0 3 4.83E-02 3.19E-01 1.12 1.14 81 
18 54142526 rs10503022 C 3.93E-04 3.93E-04 1.32 1.32 0 3 6.83E-04 4.23E-03 1.24 1.24 30 
18 55369820 rs2851871 G 6.70E-04 6.70E-04 1.27 1.27 0 3 7.48E-04 7.48E-04 1.20 1.20 0 
18 59736240 rs724558 C 4.17E-04 4.17E-04 1.35 1.35 0 3 3.66E-02 3.23E-01 1.15 1.16 81 
18 69328006 rs2156186 A 6.39E-04 6.39E-04 1.26 1.26 0 3 3.08E-05 3.08E-05 1.25 1.25 0 
18 69395672 rs12454180 G 7.51E-04 7.51E-04 1.25 1.25 0 3 1.05E-03 1.27E-03 1.19 1.19 3 
18 69620647 rs1430540 C 7.00E-04 9.51E-02 0.80 0.80 76 3 2.81E-02 3.27E-01 0.89 0.88 83 
19 15591767 rs8107048 A 7.43E-04 4.43E-02 1.32 1.32 64 3 2.21E-03 5.29E-02 1.22 1.23 61 
19 17413306 rs11667945 G 3.86E-04 3.86E-04 1.27 1.27 0 3 6.88E-03 9.25E-02 1.16 1.16 63 
20 3740226 rs2282128 T 7.48E-04 7.48E-04 1.25 1.25 0 3 4.22E-02 2.72E-01 1.11 1.13 76 
20 51222125 rs2801008 G 8.57E-05 1.55E-02 1.33 1.33 61 3 8.05E-03 2.29E-01 1.16 1.18 83 
20 52246231 rs2145827 A 9.06E-04 9.06E-04 0.78 0.78 0 3 9.15E-04 9.15E-04 0.82 0.82 0 
21 23383873 rs2827841 C 4.32E-04 2.32E-02 1.27 1.26 58 3 3.46E-02 3.48E-01 1.12 1.13 83 
21 23385645 rs1506002 T 1.01E-04 3.34E-02 0.75 0.75 70 3 7.10E-03 2.24E-01 0.86 0.85 83 
21 23452912 rs198047 G 2.22E-04 2.22E-04 0.73 0.73 0 3 2.21E-04 2.21E-04 0.78 0.78 0 
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21 23460356 rs198052 T 7.79E-04 7.79E-04 0.75 0.75 0 3 1.11E-03 1.11E-03 0.80 0.80 0 
21 23461389 rs2827944 G 7.79E-04 7.79E-04 0.75 0.75 0 3 9.97E-04 9.97E-04 0.79 0.79 0 
21 42407904 rs2187240 A 6.68E-04 6.68E-04 0.67 0.67 0 3 2.39E-02 1.75E-01 0.82 0.80 71 
22 25327482 rs2301440 T 7.06E-04 7.06E-04 0.80 0.80 0 3 3.01E-02 2.44E-01 0.89 0.89 75 
22 25336189 rs2267103 A 9.47E-04 9.47E-04 0.79 0.79 0 3 1.77E-03 6.56E-03 0.84 0.84 26 
22 31098551 rs5749412 T 4.34E-04 4.34E-04 0.69 0.69 0 3 1.06E-02 1.44E-01 0.81 0.80 68 
22 31109227 rs2413113 T 8.51E-04 8.51E-04 1.25 1.25 0 3 9.22E-03 7.16E-02 1.15 1.15 55 
22 31138355 rs2049948 A 7.01E-04 7.01E-04 1.27 1.27 0 3 3.84E-03 2.66E-02 1.18 1.18 44 
22 31153071 rs1543320 G 1.58E-04 1.58E-04 0.78 0.78 0 3 2.74E-03 5.92E-02 0.85 0.85 62 
22 31526693 rs9619311 C 8.74E-04 9.07E-03 1.27 1.27 39 3 9.25E-03 1.08E-01 1.16 1.17 66 
22 31582041 rs1427378 G 3.94E-04 1.72E-03 1.32 1.32 22 3 9.75E-03 1.50E-01 1.17 1.18 73 
22 31595922 rs1543803 T 2.48E-04 4.48E-03 1.32 1.32 40 3 4.74E-02 3.79E-01 1.12 1.14 85 
22 31602699 rs5754322 C 9.42E-04 9.42E-04 1.31 1.31 0 3 8.63E-02 3.89E-01 1.12 1.13 81 
22 33217654 rs130698 T 1.72E-05 1.72E-05 1.88 1.88 0 3 1.82E-04 1.41E-02 1.57 1.56 57 
22 33500735 rs10483184 T 2.69E-04 2.69E-04 1.54 1.54 0 3 9.14E-03 1.23E-01 1.27 1.30 70 
22 35754794 rs8141597 C 9.45E-04 9.45E-04 0.79 0.79 0 3 2.26E-03 3.23E-03 0.84 0.84 7 
22 35758545 rs228129 A 6.77E-04 6.77E-04 0.80 0.80 0 3 3.63E-02 2.75E-01 0.90 0.89 76 
22 43437912 rs136911 A 7.78E-04 7.78E-04 0.79 0.79 0 3 9.66E-03 9.95E-02 0.86 0.86 61 
CHR: Chromosome; BP: Basepair position; SNP: Single Nucleotide Polymorphism; A1: Analysed allele; P: p-value  (fixed effect); P(R); p-value (random effect) 
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